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SUMMARY
Cirrhosis is a leading cause of death in the United States and has severe and
costly complications. Because of the clinical significance of cirrhosis, it is important
that noninvasive methods be developed to detect cirrhosis early and to monitor its
progression with advancing liver disease. Previous studies on portal venous hemody-
namics have been performed mainly with ultrasound with mixed results. Magnetic
Resonance Imaging offers several advantages over ultrasound including acquisition of
both high quality anatomical and hemodynamic information.
Phase-Contrast MR was used to gather velocity data for the portal venous sys-
tem. Methods were developed to perform registration, segmentation and isolation of
the portal vein geometries and velocity data. Computational Fluid Dynamics was
also employed to further investigate the flow within the portal vein, beginning with
idealized models and then subject specific models.
The idealized models provided a simple initial adaptation of the CFD methodology
and provided some insights that were carried forward to the normal subjects and
patients such as parabolic-like velocity profiles, streamlining in the portal vein and
quasisteady flow assumption.
The data set included nine normal subjects and four patients. Velocity data for
the portal vein, superior mesenteric vein, splenic vein and the right or left portal
vein were acquired in varying numbers for both data sets. Even with the limited
number of subjects a few parameters were significant. Patients with cirrhosis had a
significantly increased portal vein area and a significantly decreased average velocity
per liver volume and velocity variance. Patients with cirrhosis had a significantly
xvi
increased splenic vein area and average flow rate per liver volume. While these results
are preliminary due to small sample size, they are promising and require further




Cirrhosis of the liver is one of the leading causes of death in the United States.
Consequences of cirrhosis are portal hypertension (a result of altered hemodynamics,
blood flow, in the liver), enlarged spleen, ascites (fluid accumulation in the abdomen),
and varices (dilation of intra-abdominal veins that can lead to bleeding and death)
[2]. Because of the clinical significance of cirrhosis, it is important that noninvasive
methods be developed to detect cirrhosis early and to monitor its progression with
advancing liver disease. There is little detailed hemodynamic knowledge available
for the normal liver, and therefore departures from physiological hemodynamics that
arise from disease are difficult to interpret.
Previous hemodynamic studies have used a variety of imaging methods; Doppler
ultrasound, venography, angiography, scintiphotosplenoportography, and percuta-
neous transhepatic portography [9, 10, 13, 18, 20, 22, 24, 40, 43]. The modalities of
Magnetic Resonance Imaging (MRI) and Phase Contrast MRI, a method developed
for quantitatively measuring blood flow, have been used limitedly. These methods
have the advantage of being completely noninvasive and of providing both anatom-
ical, including vessel area, and hemodynamic information and thus may yield more
precise evaluation for improved assessment of cirrhosis in the clinical setting.
This research will examine the use of MRI to investigate normal and diseased
portal vein hemodynamics and to potentially identify characteristics for use in clinical
diagnoses. A companion technology, computational fluid dynamics (CFD), will be
employed to develop computational models of portal vein hemodynamics so that a
more thorough understanding of normal and diseased states may be achieved.
1
Overall Hypothesis: The hemodynamic characteristics of the portal venous
system are indicators of liver function, liver disease and progression, specifically of
cirrhosis, and can be utilized to improve the clinical evaluation and management of
patients.
Specific Aim 1: Develop an idealized, but physically representative model of the
portal venous system to preliminarily investigate portal venous flow and study the
effect of boundary conditions and geometric shape on flow patterns.
Specific Aim 2: Characterize hemodynamics in the normal adult portal venous
system.
Specific Aim 3: Characterize hemodynamics in the portal venous system in
patients with cirrhosis and portal hypertension.
Specific Aim 4: Identify differences in hemodynamic characteristics of the portal
venous system between normal and diseased subjects.
The main purpose of this work is to understand portal venous hemodynamics in
greater detail than is currently known and to investigate the potential of relating this
knowledge to the progression of liver disease. If a relationship between hemodynamic
characteristics and disease can be developed using the methodology, this knowledge
may ultimately be used to non-invasively determine stages of cirrhosis; assess the risk
of portal hypertension, ascites, and varices; develop and evaluate accurate treatment
plans; and possibly improve the index used for transplant wait list status. Thus,





2.1 Liver Anatomy and Physiology
The liver is the largest solid organ and gland in the body weighing approximately 1500
grams. It is located predominantly in the upper right quadrant of the abdomen. The
liver appears glossy and is red in color, wrapped in a fibrous capsule. The anterior
surface is triangular in shape and contains two main lobes, the right and left (Figure
1). There are also two accessory lobes, the caudate and quadrate, that are visible on
the posterior surface of the liver. Ligaments connect the liver to the diaphragm and
abdomen wall, providing stability [4].
Figure 1: Anterior View of Liver [5]
The structural unit of the liver is the lobule, which is formed by the connective
tissue capsule (Figure 2). The hepatic lobule is roughly hexagonal in shape and is
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separated from other lobules by the interlobular septum. There are about one million
lobules in the liver each with a diameter of 0.5-2mm [5]. The lobule is made up of
plates of hepatocytes that radiate from a central vein in the center. At the vertices
of the lobule is an area called the portal triad (Figures 2 & 3), which contains an
artery, vein, and bile duct [5]. While the lobule is the structural unit, the acinus is
the functional unit. The acinus is an elliptical mass of hepatocytes with zones that
radiate out from the vascular system (Figure 3). Zone 1 is closest to the vasculature
while zone 3 is farthest away [5].
Figure 2: Hepatic Lobule [4]
Figure 3: The Acinus [5]
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The liver receives blood from two sources, the hepatic artery and the portal vein.
The blood from the portal vein supplies 80% of the liver’s blood and contains nutrients
that were absorbed from the digestive tract [28]. The liver vasculature can be seen
in Figure 4. Sinusoids are low pressure vascular channels which receive blood at
the portal triad region from terminal branches of the portal vein and hepatic artery
(Figure 5). The blood then passes through the sinusoid into the central vein where
it empties into the hepatic vein and eventually the inferior vena cava. There is only
one direction of flow, with no recirculation.
Figure 4: Liver Vasculature [4]
There are several sinusoidal lining cells. The first are endothelial cells, which are
unlike other endothelial cells. They have fenestrae or holes, which are about 1000A in
diameter that control the interchange between the blood and the perisinusoidal space.
The endothelial cells are unique because they lack a basal lamina. Kupffer cells lie on
the luminal surface of the endothelium. They are monocyte derived cells that engulf
pathogens, cell debris, and damaged blood cells. They can also present antigens that
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will stimulate an immune response. Kupffer cells also store iron, some lipids, and
heavy metals. Hepatic Stellate cells (HSC), also known as Ito cells and fat storing
cells, have many functions. They synthesize apolipoproteins and prostaglandins, pro-
duce cytokines and express membrane receptors, synthesize the extracellular matrix,
and are involved with matrix degradation. HSCs have the ability to contract the
sinusoid, regulating sinusoidal diameter and tone. After an injury HSCs can be acti-
vated causing excessive proliferation [5]. The last group of cells is the Pit cells, which
are natural killer cells that fight against tumor cells and viral infections [8]. The
hepatocytes perform the metabolic, endocrine, and secretory functions of the liver.
They are bipolar cells with the apical side facing the sinusoid and the lateral sides
joining other hepatocytes and forming bile canaliculi [5]. The sinusoid and sinusoidal
lining cells can be seen in Figure 5.
Figure 5: Sinusoid [2]
The liver has three main categories of functions; metabolic regulation, hematologi-
cal regulation, and bile synthesis and secretion. The general function of the metabolic
regulation is to remove and store excess nutrients and correct deficiencies, deplet-
ing stored reserves and synthetic activities. The liver is involved in carbohydrate
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metabolism by stabilizing blood glucose levels. The liver manages lipid metabolism
by regulating the circulating levels of triglycerides, fatty acids, and cholesterol. The
liver can also synthesize lipoproteins, cholesterol, and phospholipids. The liver re-
moves excessive amino acids from circulation and uses them to synthesize proteins or
converts them to lipids or glucose for storage. The liver is responsible for removal of
waste products from the blood, which are then inactivated and stored or excreted.
The liver performs deamination, which produces ammonia that is then excreted by
the kidneys. Vitamins A, D, E, K, and B12 are absorbed and stored in the liver until
needed. Hemoglobin is processed for its iron content, which is converted to ferritin
and stored. Last, the liver removes and breaks down circulating drugs. How fast the
liver does this is taken into account in the dosage of medicines [28].
The general function of the liver’s hematological regulation is to regulate and filter
the blood. As mentioned previously, Kupffer cells have the ability to engulf cells and
debris in the blood and present antigens, stimulating an immune response. The liver
is responsible for synthesizing and releasing into circulation blood plasma proteins
such as albumins, transport proteins, clotting proteins, and compliment proteins.
Circulating hormones are also removed in the liver, which is the primary site for
absorption and recycling of epinepherine, norepinephrine, insulin, thryroid hormones,
and steroid hormones. Antibodies are absorbed and broken down releasing the amino
acids to be recycled. Toxins that are lipid soluble are absorbed and stored in the liver
forever, such as DDT, while other toxins are removed and broken down or excreted in
bile [28]. Fluid and proteins flow from the blood into the perisinusoidal space which
collects into lymphatic capillaries. Half of the lymph is formed in the liver [5].
The last function of the liver is bile synthesis and secretion which will be discussed
in detail in the biliary system.
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2.2 Biliary System
The biliary system consists of organs and ducts that are involved in the production
and transportation of bile (Figure 6). The function of the system is to remove organic
anionic compounds from circulation and aid in digestion. Bile is a greenish yellowish
fluid that consists of waste products, cholesterol, water, small amounts of ions, biliru-
bin and bile acids [3]. The first step in the bile formation process is the uptake of
organic anionic compounds by the hepatocytes. Organic anionic compounds include
organic anions such as bilirubin and bromsulfophthalein (BSP), and bile acids [8].
Figure 6: Biliary System [3]
Bile acid production is a major pathway for removing cholesterol. There are two
types of bile acids, cholic acid and chenodeoxycholic acid. Once synthesized they are
secreted into the bile canaliculi, which is emptied into the small intestine where the
bile acids help with fat digestion. They are reabsorbed and again taken up by the
liver. This is called enterohepatic recirculation (Figure 7); 95% of bile acids undergo
this process and are recycled 6-10 times daily [2].
Another major component of bile is bilirubin, which is the end product of the
degradation of the heme group from hemoproteins. Bilirubin is toxic but is rendered
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Figure 7: Recycling of Bile Acids [2]
harmless by binding to albumin and rapid excretion by the liver. It is taken up
by hepatocytes by facilitated diffusion that requires chlorine. Once inside the cell,
bilirubin must be conjugated if it is not already, and then it is secreted into the bile
canaliculi [8].
The bile canaliculi (Figure 8) are half tubules that are carved out of the hepatocyte
surface. They are formed by tight junctions which provide a barrier for leakage into
and out of the canaliculi. The bile canaliculus contains actin and microvilli and is
supported by a complex cytoskeleton [8].
Figure 8: Bile Canaliculus [5]
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Bile formation is initiated by active secretion of bile acids and other organic an-
ionic compounds. There are two components. The first is the bile acid dependent
fraction which is related to secretion via the ATP-dependent bile salt export pump
(BSEP). The second is the bile acid independent fraction related to secretion of other
organic anions by ATP dependent Multi-Drug Resistant Protein 2 (MRP2). Both
cases generate osmotic gradients that induce water flow from the sinusoid [2]. Con-
trol of bile formation and flow is dependent on the supply of bile acids, which is
related to the rate of bile acid recirculation. Vagal stimulation is also a weak stim-
ulant. There are several gastrointestinal hormones involved such as cholecystokinin
(CCK), a weak stimulant, gastrin, a weak stimulant, secretin, a strong stimulant
for ductal bile formation, glucagons, a modest stimulant, and somatostatin, a strong
inhibitor [2].
After the bile is secreted into the bile canaliculus, it is collected in a system of
ducts that lead to the right and left hepatic ducts and then to the common hepatic
duct. The hepatic duct then joins the cystic duct from the gall bladder to form
the common bile duct, which connects to the duodenum through the sphincter of
Oddi (Figure 9). When bile is not needed, it is diverted into the gall bladder. After
food is eaten, the gallbladder contracts releasing the bile [3]. Contraction of the bile
canaliculi involves signaling between cells via gap junctions. The contractions occur
in peristaltic waves at about 1.5-3 contractions per minute [8]. As the bile moves
along the ducts its composition is changed by the epithelial cells lining the duct, the
cholangiocytes. The changes include altering the water and electrolyte content.
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Figure 9: Extrahepatic Bile Ducts [36]
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2.3 Liver Disease
Cirrhosis is one of the leading causes of death in the United States and is the final
common histological pathway for a wide variety of liver diseases [2]. Cirrhosis is a
diffuse hepatic process characterized by fibrosis and the conversion of normal liver
architecture into structurally abnormal nodules [36]. Common causes of cirrhosis
include Hepatitis C (26%), Alcoholic liver disease (21%), Hepatitis C plus alcoholic
liver disease (15%), Cryptogenic causes (18%), Hepatitis B (15%), and misc (5%) [36].
A serious complication relating to cirrhosis is portal hypertension, which is high
blood pressure in the portal vein. Portal hypertension is caused by altered hemody-
namics in the liver. One alteration is increased resistance to flow of blood through
the liver and a second is a large increase in the amount of blood trying to enter the
liver from the splanchnic circulation [36]. A normal hepatic venous pressure gradient
is 3-6 mmHg. Above that range is portal hypertension with a threshold for ascites at
8 mmHg and another threshold for varices at 12 mmHg [36].
Causes of increased resistance of blood flow into the liver can be presinusoidal,
intrasinusoidal, or postsinusoidal (Figure 10). Presinusoidal causes include blockage of
the main portal vein or annular fibrosis of intrahepatic portal venules. Intrasinusoidal
causes are mainly due to cirrhosis and include subendothelial deposition of collagen in
the space of disse, distortion from regenerating nodules, constriction due to synthesis
of NO and increased vasocontrictors (endothelin), and impaired hepatic removal and
increased consumption of endotoxins or compression by tumors. Postsinusoidal causes
include veno-occlusive disease, obstruction of small hepatic venules, Budd Chiari
Syndrome, obstruction of the main hepatic vein, and severe right side congestive
heart failure [36].
Increased splanchnic flow can be caused by a hyperdynamic circulation state found
in cirrhosis. Cirrhosis brings increased synthesis of NO, increased systemic glucagon
concentration, decreased sensitivity to vasoconstrictors and increased cardiac output
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Figure 10: Causes of Portal Hypertension [36]
[36].
Consequences of portal hypertension (PH) include enlarged spleen, portal venous
collaterals to systemic veins bypassing the liver (varices), accumulation of fluid in the
peritoneal cavity (ascites), and edema [36]. Common varices are gastroesophageal,
retroperitoneal, periumbilical, rectal, and diaochragmatic-perisopheageal (Figure 11)
[36]. Variceal hemorrhage is the most common complication associated with PH.
Of patients with cirrhosis, 90% develop varices, 30% of varices bleed, and the first
epidsode of variceal hemorrhage carries an estimated 30-50% mortality rate [36].
Treatment for PH includes decreasing intrahepatic vascular resistance using NO
precursors and blocking angiotensin II and endothelin receptors. Another treatment is
to constrict splanchnic arterioles to decrease portal venous flow using beta-adrenergic
13
Figure 11: Common Varices [36]
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antagonist and splanchnic selective vasopressin analogue. A third option is to inhibit
splanchnic vasodilation by decreasing NO synthesis by inhibiting eNOS, using endo-
toxin formation in the gut and inhibiting CCK, VIP and glucagon receptors. A fourth
treatment option is to decrease intravascular volume using diuretics and restricting
sodium. The last treatment option is to decompress the portal system by diverting
blood to the systemic circulation using a surgical splenorenal or porto-caval shunt or
the transjugular intrahepatic porto-systemic shunt (TIPS) (Figure 12) [36].
Figure 12: Liver Shunts [36]
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2.4 Liver Transplantation
Over the past several decades, the need for livers has increased more rapidly than the
availability of livers as illustrated in Figure 13. The next figure gives the number of
people on the waiting list for various organs as of April 21, 2008 (Figure 14). The data
were provided by the United Network for Organ Sharing (UNOS). While the kidney
accounts for most of the people on the waiting list (77%), the liver has the second
largest number of people (17%). The mortality of the waiting list has increased 575%
from 1988 to 1997 [7].
Figure 13: Available vs. Waiting Livers [36]
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Figure 14: U.S. Waiting List by Organ [7]
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Candidates for transplantation include cirrhosis, primary metabolic disease, acute
liver failure, malignant disease, cholestatic liver disease, and others. Criteria for trans-
plantation are partially based on the Child-Pugh Scoring System (Figure 15) which
takes into account encephalopathy, ascites, bilirubin and albumin levels, prothrombin
time, and type of disease. UNOS’s criteria places candidates into four statuses, Status
1 is top priority and then 2A, 2B, and 3 [36].
Figure 15: Child-Pugh Score [36]
Donors must be between the ages of 2 months and 60-65 years of age. The livers
are matched blood type specific, but can be mismatched in emergency situations.
The donor livers are tested for Hepatitis B and C viral markers, CMV antibodies,
and HIV [36].
There are four different types of liver transplant surgeries; Orthotopic, Piggyback,
Split Liver, and Living Donor. Orthotopic liver transplantation takes an average of
8 hours operative time. Before this however, the donor liver is harvested. First,
the inferior vena cava (IVC) is cut above the liver and then below the liver. An
aortic patch is created that includes the celiac trunk and the superior mesenteric
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artery (SMA). The celiac trunk and mesenteric artery are separated unless there are
accessory hepatic arteries stemming from the SMA. The portal vein is cut about 1-2
cm. from its origin and the bile duct is also cut. The common, external, and internal
iliac arteries and veins are also harvested in case grafts are necessary [30]. In the
recipient, the liver is removed with the attached portion of the IVC. Some patients
that can not withstand having their IVC and their portal vein clamped are put on
veno-venous bypass. Venous blood from the leg and portal vein are rerouted through
a pump into an arm vein. The order of anastomoses is first the supra-hepatic IVC,
intra-hepatic IVC, portal vein, hepatic artery, and last the bile duct (Figure 16).
Figure 16: Anastomoses [6]
For both the hepatic artery and the portal vein, if there is not enough length,
an artery or vein graft from the donor maybe used. It is important not to put the
artery or vein in tension. Artery anastomoses are sometimes sewn with a growth
factor patch that helps to prevent anastomotic strictures. When bile duct sizes are
mismatched, the problem can be handled in three ways; one bile duct can be cut
up the side expanding the opening, for two small bile ducts both ends will be cut
to increase the diameter at the anastomoses, and with large to small bile ducts the
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larger duct will be stitched over [30].
Before the bile ducts are anastomosed, a T-tube is put in place that allows bile
to drain outside the body. This is a precaution because it is dangerous to have a
build up of bile in the body. If the recipient’s bile duct is too badly damaged, a roux-
en-Y procedure can be performed where the intestines are transected and one end is
attached to the donor bile duct while the other end is reattached to the intestines [30].
The next type of liver transplant is the piggyback transplant, in which the recip-
ient’s IVC is left intact. This recipient may then not require a veno-venous bypass.
The top of the donor IVC is anastomosed to the recipient’s hepatic vein stumps.
Due to the high demand for livers, donor livers have been split to give to two
people. This was initially done in children where there is a restriction in how large
the donor liver can be. The donor liver is usually separated into the right and left
lobes as seen in Figure 17 [30].
Figure 17: Split Liver Transplant [36]
A living donor can also donate a portion of their liver. The size of the recipient
and the risk to the donor dictates which portion of the liver is donated. In typical
adult donor, the left lobe with all the major vessels remains in the donor and the
right side goes to the recipient [30]. The liver regenerates almost to pre-surgery mass
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in eight weeks [6]. A typical living donor transplant can be seen in Figure 18.
Figure 18: Living Donor Transplant [6]
Among the most feared complications of liver transplants are vascular complica-
tions which occur in about 2-25% of the cases [29] [17]. One such vascular complication
is hepatic artery thrombosis (HAT), which is more frequent in children. This is pos-
sibly because of discrepancy in arterial size and lack of sufficient magnification to see
the artery [17]. Thrombosis of the hepatic artery occurs more often than thrombosis
of the portal vein or IVC. After transplant, the patient undergoes routine ultrasound
for the first few days and then at longer intervals. HAT is often discovered this way
and angiography is performed to confirm. Treatment options include thrombectomy
and donor or synthetic arterial graft. But the main course of action is retransplan-
tation (50%) [29] [37]. Hepatic artery stenosis (HAS) is also a problem which again
is diagnosed via ultrasound and confirmed by angiography. Treatment includes revi-
sion of the anastomoses, repositioning of the artery, saphenous vein patch, and aortic
interposition graft [30]. Reduction in hepatic artery blood flow can present as biliary
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complications because the hepatic artery is the only source of oxygenated blood to
the bile ducts. Detection and correction must occur within 24 hours or the biliary
epithelium will die and the liver will fail [17]. Portal vein thrombosis is rare and has
many causes such as twists and kinks in the vein, anastomotic strictures, excessive
length of vein and many more. Treatment involves thrombectomy, venous graft, and
anticoagulation therapy. Portal vein strictures occur at tight anastomoses, kinks and
twists, or where external pressure is applied. Diagnosis is made using ultrasound and
angiography. Treatment includes revision of anastomoses, transhepatic portal vein
catheterization, and percutaneous transhepatic angioplasty with or without a stent
placement. Hepatic vein stricture and thrombosis occur infrequently and are diag-
nosed by ultrasound and venography. Treatment includes percutaneous transhepatic
angioplasty, stenting, and retransplantation [30].
Biliary complications are usually caused by anastomotic strictures, which develop
mainly from technical complications. Treatment includes internal stent, percutaneous
balloon dilation, reanastomoses, and if not previously done, a roux-en-Y anastomosis
[30].
2.5 Significance
Based on the above knowledge, several conclusions can be drawn. The first is that the
liver is an important organ that provides many life affecting functions. The second is
that incidence of and deaths due to liver disease are increasing, and the gap between
need and supply of transplantable livers is increasing. Thus, being able to more
accurately diagnose and treat individuals as well as determine risk of complications
such as portal hypertension and varices are of growing importance and will affect a




Previous studies have focused on the portal vein and its left and right branches,
the splenic vein, the spleen, and splenic artery using a variety of methods including
Doppler ultrasound (the most popular), limited MR, venography, angiography, scin-
tiphotosplenoportography, and percutaneous transhepatic portography [9, 10, 13, 18,
20, 22, 24, 40, 43]. Measurements include velocity, flow rate, and area/diameter. In-
dices used for venous comparison include hepatic venous pressure gradient (HVPG),
venous pulsatility index (VPI) and congestion index (CI) defined as:
HV PG = free hepatic venous pressure− wedged hepatic venous pressure (1)
V PI = (max frequency shift−min frequency shift)/max frequency shift (2)
CI = V essel area/max velocity (3)
Measurements used for arterial comparison include velocity, flow rate, and area/diameter.
Indices used include the above congestion index as well as pulsatility index (PI) and
resistive index (RI) defined as:
PI = (peak systolic velocity − end diastolic velocity)/mean velocity (4)
RI = (peak systolic velocity − end diastolic velocity)/peak systolic velocity (5)
3.1 Portal Vein
In general with cirrhosis, many studies that include US and MR measurements, have
found a significant decrease in portal blood velocity (PBV) [9, 15, 20, 31, 32, 40, 43].
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Zoli et al. [45] found that in diseased subjects a PBV of less than 10 cm/s charac-
terized a shorter survival rate and that the prognostic significance of the Child-Pugh
score increased when PBV was included. Nanashima et al. [32] and Taourel et al. [38]
correlated PBV, measured non-invasively, to HVPG. Another study though, of 375
patients showed no correlation between PBV and HVPG [15]. Therefore the corre-
lation is still inconclusive. Since HVPG is an invasive measurement, correlation to a
non-invasive parameter may eliminate the need for the invasive test illustrating the
importance of such as correlation. Nanashima et al. [32] also showed a low correlation
between MR PBV measurements and US PBV measurements, which further supports
the use of MR to measure PBV.
The difference in portal blood flow (PBF) between normal subjects and patients
remains unclear. Kayacetin et al. [20] and Vyas et al. [40] found a significant decrease
in PBF in patients, but Yin et al. [43] found a significant increase in PBF. Several
other studies found no significant difference between the two groups [9,15,22,31]. With
cirrhosis the resistance to flow in the liver increases, but flow from the splenic vein
increases which can maintain normal PBF even under portal hypertensive conditions.
Again there are mixed findings on the correlation of PBF to HVPG [15, 38]. The
ratio of SV flow to PV flow was found to increase and in some cases doubled with
cirrhosis [22,43]. Since the portal vein connects two collateral beds, it is hypothesized
that the flow within the portal vein would be steady, however, Gallix et al. [14] found
that in healthy individuals the portal vein had a small venous pulsatility index (VPI)
and another study showed an increase in VPI in patients [21]. Burkart et al. [12]
showed a significant correlation between MR and US PBF measurements, however
this was with a limited number of subjects. Error is expected in the US measurement
of flow since the area of the vessel is not directly measured but calculated from a
diameter measurement using the area equation for a circle. In some cases the PV
cross-section may not be a perfect circle.
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In general with cirrhosis, the portal vein diameter increases [9, 20, 44]. However,
other studies found no significant difference in diameter between normal subjects
and patients [22, 33]. PV diameter was also correlated to liver fibrosis by Lu et
al. [25]. The significant increase in PV congestion index (CI) is well supported by
the literature [9, 20, 22, 43]. However, the clinical usefullness of the parameter is still
unknown. Flow data for the portal vein can be found in Tables 1 and 2.
Table 1: Data for Portal Vein in Healthy Subjects
Parameter Yin 2001 [43] Kutlu 2002 [22] Kayacetin 2004 [20]
Velocity (cm/s) 30.4 ±7.2a 19.6 ±4.4 12.6 ±2.9
Flow Rate (ml/min) 1040 ±190 1109 ±278 1208 ±184
CI 0.03 ±0.001 0.05 ±0.016 0.03 ±0.01
Method Doppler US Doppler US Doppler US
aCross Sectional Velocity Maximum
Table 2: Data for Portal Vein in Patients
Parameter Yin 2001 [43] Kutlu 2002 [22] Kayacetin 2004 [20] Vyas 2002 [40]
Velocity
(cm/s)
14.9 ±3.1a 17.3 ±9.5 7.5 ±6.5 5.3 ±1.1
Flow Rate
(ml/min)
1361 ±501 1361 ±1337 755 ±355 380 ±103
CI 0.14 ±0.06 0.076 ±0.044 0.11 ±0.6
Method Doppler US Doppler US Doppler US Doppler US
aCross Sectional Velocity Maximum
3.1.1 Streamlining of PV Flow
Physicians have hypothesized that the blood flowing from the SMV and SV prefer-
entially distribute into the RPV and LPV, respectively. This theory developed due
to the high predilection of the right lobe of the liver for disease. Since the SMV
blood is coming from the digestive tract it can carry toxins such as alcohol and other
infectious agents. This could explain the high incidence of cirrhosis in the right lobe.
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Tsukuda et al. [39], using MR and blood tagging, matched the signal in the PV to
its contributing vessel. Before a meal, the SV was the major contributor to the PV
signal and flowed in the center of the PV in the majority of subjects. The SMV
flow was split bilaterally. While the tagged blood was not directly imaged in the PV
branches (some of the vessels were captured with the PV), in a few example subjects
there was no dominant contributor to the RPV. After a meal, when the SMV flow
was thought to increase, the SMV flow dominated the PV signal and pushed the SV
flow to the left side. The SMV also became the clear contributor to the RPV. In both
cases there was still little mixing of the two flows agreeing with the streamline effect
in the PV. This study demonstrates that when toxins would be at their highest levels,
after a meal, the SMV is the major contributor to the RPV. However under fasting
conditions the SMV contribution to the RPV may be subject specific and could be
genetic.
3.2 Right Portal Vein
Cirrhosis is located preferentially on the right side of the liver and therefore the
resistance in that lobe would increase and one would expect the RPV velocity and
flow to decrease. These decreases have been shown to be significant when compared
with normal subjects [22,23,43]. Kutlu et al. [22] demonstrated a significant decrease
in diameter and Yin et al. [43] an increase in congestion index. The ratio of RPV flow
to PV flow was found to decrease possibly indicating changes in flow division or just
a decreased flow in general [22]. An increase in the bluntness of the velocity profile
as calculated by a velocity profile shape parameter was seen by Yin et al. [43]. Flow
data for the right portal vein can be found in Table 3.
3.3 Spleen and Splenic Artery
Spleen enlargement is a hallmark of portal hypertension and cirrhosis. Shah et al. [35]
related spleen volume to portal vein cross sectional area and portal vein blood flow
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Table 3: Data for Right Portal Vein
Healthy Cirrhotic
Parameter Yin 2001 [43] Kutlu 2002 [22] Yin 2001 [43] Kutlu 2002 [22]
Velocity
(cm/s)
13.1 ±2.8a 20.1 ±3.8 9 ±2.8b 15.7 ±5.9
Flow Rate
(ml/min)
407 ±128 666 ±168 365 ±182 470 ±473
CI 0.07 ±0.03 0.028 ±0.075 0.1 ±0.5 0.033 ±0.02
Method Doppler US Doppler US Doppler US Doppler US
aCross Sectional Velocity Maximum
bCross Sectional Velocity Maximum
volume. Bolognesi et al. [9] found that the splenic artery resistive index and pulsatility
index significantly increased in cirrhosis.
3.4 Splenic Vein
Due to spleen enlargement, the flow from the splenic vein is usually increased. No
conclusions can be drawn about the velocity since it has been found to be significantly
lower, significantly higher, and not significantly different in several studies [15,20,22,
43]. An increase in SV diameter was found with cirrhosis [15, 20, 22, 44]. There are
reports of no significant change in the SV flow rate [15, 20] and in some cases an
increase in flow [22, 43]. The congestion index was also found to increase [20, 22, 43].
Yin et al. [43] saw a significant increase in phasic flow patterns perhaps due to the
increase in splenic artery flow. Flow data for the splenic vein can be found in Tables
4 and 5.
3.5 Correlation with Cirrhosis Grading
Based on the Child-Pugh score (Figure 15 on page 18), the hemodynamics of different
grades of cirrhosis were compared. Child’s A, B and C are based on scores of 5-6, 7-9,
and > 9 respectively [1]. The portal flow velocity (8.5 cm/s) and portal blood flow
(614.9 ml/min) were significantly decreased in Child’s C cirrhosis (and Child’s B [22])
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Table 4: Data for Splenic Vein in Healthy Subjects
Parameter Yin 2001 [43] Kutlu 2002 [22] Kayacetin 2004 [20]
Velocity (cm/s) 14 ±3.6a 17.9 ±4 23.9 ±9
Flow Rate (ml/min) 318 ±108 353 ±136 447 ±107
CI 0.05 ±0.02 0.019 ±0.054 0.04 ±0.02
Method Doppler US Doppler US Doppler US
aCross Sectional Velocity Maximum
Table 5: Data for Splenic Vein in Patients
Parameter Yin 2001 [43] Kutlu 2002 [22] Kayacetin 2004 [20]
Velocity (cm/s) 15.3 ±3.9a 18.2 ±4.8 12.8 ±1.4
Flow Rate (ml/min) 839 ±507 666 ±397 652 ±176
CI 0.08 ±0.04 0.034 ±0.019 0.08 ±0.03
Method Doppler US Doppler US Doppler US
aCross Sectional Velocity Maximum
as compared to Child’s A (velocity: 16.2 cm/s, flow volume: 1098.5 ml/min) [20].
There was also a significant increase in congestion index in the portal (0.14) and
splenic (0.08) veins in Child’s C as compared to Child’s A (portal CI: 0.06, splenic
CI: 0.04) [20].
3.6 Correlation with Esophageal Varices
The splenic artery RI and PI were higher in patients with cirrhosis and large EV
than in those with cirrhosis and no or small EV [9]. Blood flow velocity in the left
gastric vein increased as EV size increased [18]. There was a shift to an anterior
dominant flow pattern at the left gastric bifurcation as EV size increased [18]. A
higher percentage of patients with cirrhosis with hepatofugal flow verses hepatopetal
had gastro-oesophageal varices (p<0.025) [11]. In patients with large EV the portal
blood velocity and portal blood flow were significantly lower than in those without
varices [24]. Those with large EV had a significantly higher max inner portal vein
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diameter [24]. Those with EV has significantly greater splenic blood flow volume and
splenic CI [20]. Among cirrhotics, those with EV has significantly increased mean
flow volume in the splenic vein, mean SV/PT, and mean spleen size [43].
3.7 Correlation with Ascites
Those with ascites had significantly lower portal flow velocity and higher portal vein
and splenic CIs [20]. In those with cirrhosis, portal vein blood flow, portal flow veloc-
ity, and gastric mucosal blood flow were significantly lower in those with ascites [40].
Renal RI significantly increased in those with cirrhosis and refractory or responsive
ascites (higher in refractory ascites) [10]. In fulminant hepatic failure patients, found
significantly lower portal flow velocity in those with ascites compared to those with-
out [13].
3.8 MR Classifications of Cirrhosis
Traditional diagnosis of cirrhosis is by biopsy. Martin et al. [27] have shown that MR
scaling of fibrosis and inflammation from contrast enhanced MR images correlate to
histological scaling of the same measures thus potentially eliminating the need for
a biopsy especially if combined with other liver function results and perhaps flow
parameters.
3.9 Summary of Previous Research
This previous research illustrates significant changes in portal venous system hemody-
namics with cirrhosis that vary across grades of cirrhosis as well as correlations with
esophageal varices and ascites. The main parameters previously investigated were
portal vein velocity, portal vein flow rate, and congestion index. However, the role of
these parameters in a clinical setting is not well defined. The measurement method
of choice in the previous research was Doppler ultrasound. Errors associated with US
measurement include measurement of cross-sectional area (calculated by diameter
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measurement), angle of insonation of the doppler beam with vessel, and high inter-
observer variability. The method is also technically limited by patient habitus. The
modalities of Magnetic Resonance Imaging (MRI) and Phase Contrast MRI have been
used limitedly. These methods have the advantage of being completely noninvasive
and of providing both anatomical and hemodynamic information and thus may yield
more precise evaluation for improved assessment of cirrhosis in the clinical setting.
There is little detailed knowledge available for normal portal venous hemodynamics,
and therefore departures in physiological hemodynamics that arise from disease are
difficult to interpret. The specific aims of this research are designed to examine the
use of MRI to hemodynamically investigate normal and cirrhotic portal venous blood





The methodologies employed in this body of work include magnetic resonance imaging
(MRI), phase contrast- magnetic resonance imaging (PC-MRI), image processing and
computational fluid dynamics (CFD).
4.1 Magnetic Resonance Imaging
MR scanners available for use include a Philips 1.5T Intera system and a Siemans
Avanto 1.5T system located at the Emory Hospital and the Emory Clinic, respectively.
Both were equipped with a body phased array coil.
4.1.1 MR Data Acquisition
The scans were completed with the subjects in a supine position. The session began
with short reconnaissance scans using balanced fast field echo in 3 planes to locate
the portal vein. The vessel geometry, including the superior mesenteric vein (SMV),
splenic vein (SV), complete portal vein (PV), and the right and left portal vein
branches (RPV & LPV), was scanned using balanced fast field echo or steady-state
free precession technique (SSFP). The scans were breath-held contiguous slices of
3mm thickness with a resolution of at least 1.37x1.37mm.
4.1.2 PC-MR Data Acquisition
PC-MRI scans were performed during the same session as the geometry acquisition.
ECG leads or a Peripheral Pulse Unit (PPU) were applied for cardiac vector cardio-
gram gating. Velocity data were gathered from breath-hold cardiac-gated PC-MRI
using a segmented gradient echo sequence obtained from the mid-portal vein with the
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imaging plane placed at 90 degrees to the long axis of the vein. PC-MRI scans were
also done for the SMV and SV before the PV confluence and the RPV or LPV just
after the PV bifurcation. Scan parameters were as follows; slice thickness 6-8mm,
resolution of 1.17x 1.17mm, TR 24.2, TE 8, number of phases 16-20, and Venc 30-60
cm/s.
4.2 Image Processing
4.2.1 Vessel Image Segmentation
4.2.1.1 Preprocessing and Image Registration
It is necessary to preprocess the original MRI data and in some cases conduct image
registration. Since scanning is completed during breath-holds, more than one breath-
hold may be necessary to sufficiently capture the volume of interest. The subjects
may move or not hold their breath in the same position for the subsequent scans
causing misalignment between the last slice of the first scan and the first slice of the
second scan. The effect of misalignment can be seen in Figure 19 by overlapping two
adjacent slices.
To solve this problem, rigid registration is applied to two consecutive image series
Figure 19: Misalignment Before Registration
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before image segmentation is performed. Since there is no significant nonlinear de-








where f , g are the intensities of pixel pi in the two images to be aligned [19].
A translation (tx, ty) and a rotation by angle θ are applied to the second image
in order to minimize the MSD between the first image (the last image in the first
breath-hold series) and the second image (the first image in the second breathhold
series). A gradient decent approach is used to solve for the parameters (tx, ty, θ) that
minimize MSD. Figure 20 shows the result after registration, notice the overlapping
has disappeared.
After the registration, another preprocessing step is performed on the data. Since
the slice thickness is generally larger than the in-plane pixel spacing, the data was
linearly interpolated in the third direction (z-direction) to create near-isotropic voxels.
This helps to create a smoother 3D model of the veins.
Figure 20: After Registration
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4.2.1.2 Bayesian Voxel Classification
With the data properly aligned and interpolated, 3D image segmentation is performed
to segment the portal vein and its branches. A 3D voxel classification is performed on
the data using the intensity distributions of the MR images. We assume that blood
filled regions (i.e. the veins) have higher intensities as compared to the background
tissue. Each voxel is labeled as either “blood” or “background” by taking the highest
probability that the voxel belongs to its respective group. The probability of a voxel
belonging to the blood or background classification is calculated using Bayes’ rule
[16,42]:
Pr(x ∈ ck | V (x) = v) =
Pr(V (x) = v | x ∈ ck)Pr(xk)∑
γPr(V (x) = v | x ∈ γ)Pr(x ∈ γ)
, (7)
which means that given the probability density function p(V (x) | ck) of each class
ck (blood or background) and the prior probability Pr(x ∈ ck) of each class, posterior
probabilities can be calculated via the Bayes rule Equation 7 to give the probabilities
of a single voxel at position x = (x, y, z) belonging to different classes. V (x) is the
intensity of voxel x, and v is any possible value within the range of the intensity in
the images.
To determine the probability density functions for both blood and background, we
analyze the histogram of the images to determine the mean (µc), standard deviation
(σc) of each class. Then the probability density function can be approximated using
Gaussian functions with the learned mean and standard deviation in each class, thus
the likelihood of a particular voxel having a certain intensity value v given that it is
in class c ∈ {blood, background} is:






The voxels can then be labeled according to the maximum a posteriori (MAP)
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rule:
C(x) = arg max
c∈{blood,background}
Pr∗(x ∈ c | V (x) = v), (9)
where C(x) is the class that voxel x belongs to, and Pr∗ is a smoothed version of
the posterior probability obtained using the anisotropic smoothing [34] described by








where H and κ are the mean curvature and Gaussian curvature of Pr, and κ+
... =
max{κ+, 0}. ~N is the inward unit normal.
The voxel labeling result is seen in Figure 21. All blood regions are shown as
white, while the background region is the same as the original images.
Figure 21: Voxel Labeling Result
4.2.1.3 Isolating Portal Veins
Since the voxel labeling results identify all blood filled regions, the portal vein and
it’s inlets and outlets needed to be isolated. An in-house program was developed for
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this application that labeled all connected veins thus allowing the portal vein to be
selected.
4.2.2 Velocity Data Segmentation and Processing
4.2.2.1 Preprocessing
Image preprocessing was performed using a MATLAB program written for this pur-
pose. PC-MR data consists of both magnitude and phase images. The magnitude
images were cropped to isolate the vein of interest. The phase images were filtered
using a median filter:
y[m,n] = median{x[i, j], (i, j) ∈ w}, (11)
where w is a neighborhood centered around the location (m,n). Then the intensity
images were also cropped to isolate the vein of interest.
4.2.2.2 Threshold Segmentation
Image segmentation was performed using a MATLAB program written for this pur-
pose. The processed magnitude images were segmented based on a threshold criteria:
g(i, j) = 1forf(i, j) ≥ T (12)
= 0forf(i, j) > T, (13)
where T is the intensity threshold. Next, the segmented magnitude images were
used as a mask to multiply the phase images, leaving only the phase intensity infor-
mation of interest. An example can be seen in Figure 22 showing the original cropped
image and the mask.
4.2.2.3 Velocity Calculations
The segmented velocity intensities were converted to actual velocity values using a
MATLAB program we developed for this application and the relationships:
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(a) Original Magnitude Image (b) Mask





b = Venc (15)
V elocity(i, j) = a× Intensity(i, j) + b (16)
The Venc number is a parameter defined by the user and is the velocity of protons
that will produce a phase shift of 180◦. It is the maximum velocity that can be
measured without aliasing. These calculations provide 2D cross-sectional velocity
images (Figure 23).
In addition the average, maximum and minimum velocities, the flow rate, and the
area were calculated for each cross-section.
FlowRate =
∑
V elocity(i,j) × PixelArea (17)
Area = NumberofP ixels× PixelArea (18)
The above values were calculated for the entire cardiac cycle by taking the aver-
age of the cross-sectional averages. The diameter and Reynolds Number were also
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ρ× AverageV elocity ×Diameter
µ
, (20)
where ρ is blood density (1060 kg/m3) and µ is blood viscosity (0.0035 kg/ms).
4.3 Computational Fluid Dynamics
Computational fluid dynamics obtains numerical solutions to fluid flow problems us-
ing computers. The governing equations are the Navier-Stokes equations which are
shown in Equation 21 for an incompressible fluid. The first equation is the continuity
equation which is basically the conservation of mass. The second equations represent
the conservation of momentum. On the left side is density multiplied by acceleration
which is the material derivative of velocity. On the right side is the sum of the forces























































































These equations contain coupled non-linear partial differential equations. Ana-
lytical solutions can be found if the non-linear terms drop out or are very small in
comparison to other terms and thus can be neglected. In most fluid flows, especially
blood flow, the non-linear terms can not be neglected and numerical methods must
be used to solve these equations. In CFD, the governing equations are discretized
and can be solved with the help of a computer to find approximate solutions. These
methods involve developing a numerical grid of the anatomy of the region of interest,
as obtained from the MRI scans. It is necessary to provide velocity or flow boundary
conditions for the inflow and outflow of the region of interest. These data will be ob-
tained from the PC-MRI results. At the interior grid points, the governing equations
are replaced by discretized approximations.
4.3.1 Grid Generation
The first step in creating a grid for the geometry is making sure that the geometry
is in the correct form. After isolating the portal vein, we are left with a series of
2D cross-sections. These cross-sections are imported into MIMICS which creates a
smooth surface.
This smooth surface is then trimmed down. Next contour lines are manually drawn
on the geometry, this divides the geometry into panels which are then subdivided
into patches. It is ideal for the patches to be equilateral. These patches are then
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the containers for grids. The resolution of the grid is set and the grid automatically
generated. A Non-Uniform Rational B-Spline (NURBS) Surface is created based on
the grids that lie in the patches on the panels. NURBS is a set of smoothly connected
curves imposed on a surface to make the surface smooth. The surface is saved in
IGES format which can be imported into GAMBIT.
GAMBIT is the grid generation component of the FLUENT package. The IGES
geometry file was imported into GAMBIT. The faces of the outlets and inlets were cre-
ated from the edges. Then a volume was created by stitching all faces together. Both
the inlets and outlets needed to be extended so local coordinate systems were estab-
lished and a line created perpendicular to the face being extended. Then the face was
swept along the line forming the extension. Once all extensions were completed they
were added to the original volume. Next the volume was automatically meshed with
the following specified; meshing scheme and mesh node spacing. The meshing scheme
is composed of the elements and type. The elements’ parameter defines the shape of
the elements used to mesh. The elements selected were Tet/Hybrid which specifies
that the mesh is primarily composed of tetrahedral elements and where appropriate
may include hexagonal, pyramidal, and wedge elements. The type parameter defines
the meshing algorithm which in our case was Map, creating a regular structured grid
of hexahedral mesh elements. The mesh node spacing was also set based upon the
geometry. After the geometry is successfully meshed, the zone types are specified.
The boundary types such as wall, inlet velocity and outflows are set as well as the
continuum type which is fluid. A mesh file is exported for use in FLUENT.
4.3.2 Computations
The meshed geometry was imported into FLUENT where it was scaled and the grid
points were smoothed and swapped for a minimum skewness of 0.7. Blood was spec-
ified in the materials database with a density of 1060 kg/m3 and viscosity of 0.0035
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kg/ms. The next steps are divided into Steady and Unsteady Flow Calculations.
4.3.2.1 Steady Flow Calculations
The boundary conditions were for the inlets and outlets. The SMV and SV inlets
were classified as velocity inlets and the velocity was taken from literature or MR
data. All outlets were classified as outflow in which the flow split was again taken
from literature or MR data. The outflow boundary condition is treated as a zero
diffusion flux for all flow variables and an overall mass balance correction.
The solver parameters were as follows. The pressure based solver was chosen due
to the modeling of low-speed incompressible flow. FLUENT solves the governing
equations for mass and momentum in order to obtain the velocity field. To do this a
control volume based technique is used. The domain is divided into discrete control
volumes based on the computational grid. The governing equations are integrated
over the individual control volumes to construct algebraic equations. The discretized
equations are linearized and solved to yield values for unknown variables. The formu-
lation for the solver was implicit. The velocity formulation was absolute and porous
formulation was superficial velocity. The Green-Gauss Cell based gradient option was
used. For the pressure-velocity coupling the SIMPLE algorithm was selected which
uses the relationship between velocity and pressure correction to enforce mass con-
servation and obtain the pressure field. Convergence was assumed when all scaled
residuals decrease to 10−3.
4.3.2.2 Unsteady Flow Calculations
The boundary conditions for the inlets were User-Defined functions of the velocity
waveform from MR data. The outlet conditions were the same as above for the steady
calculations.
The solver parameters were as follows: implicit pressure based solver, absolute
velocity, 1st order implicit, superficial velocity, and green-gauss node based gradient
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option. The pressure-velocity coupling selected was the PISO algorithm part of the
SIMPLE family but based on the higher degree of the approximate relation between
the corrections for pressure and velocity.
4.3.2.3 Visualization
Visualization was done using TECPLOT 360 which displayed results, calculated ad-
ditional variables, and performed integrations.
4.4 Flow Contribution Calculations
Physicians have noted that liver disease is located preferentially on the right side of
the liver. One hypothesis is that the right side of the liver is predominately fed by
SMV blood which is coming from the digestive system and carries toxins. Therefore
a protocol was developed to calculate the contributions of one inlet to all outlets.
First a slice perpendicular to the inlet was created. Next a grid was overlaid on the
slice. This information was used to create a macro that added streamtraces at all
of the grid points inside the vessel. The streamtraces were then extracted and run
through a separate C program that calculated to which outlet they went based on
input x, y, and z criteria. Once the streamtraces were separated by outlets, the flow
to each outlets was calculated by taking the sum of the velocities at the grid points
on the inlet multiplied by the individual grid area.
FlowRateperoutlet =
∑
V elocity(i,j) × Individual GridArea (25)
4.5 Liver Volume
The liver volumes were calculated based on manual segmentation and program cal-
culation of the volume by summing the volumes of the voxels. An example liver
segmentation for a normal subject and patient can be seen in Figure 24.
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(a) Normal (b) Patient




Specific Aim 1: Develop an idealized, but physically representative model of the
portal venous system to preliminarily investigate portal venous flow and study the
effect of boundary conditions and geometric shape on flow patterns.
5.1 Model Development
The model consists of the Superior Mesenteric Vein (SMV) and Splenic Vein (SV)
joining to form the Portal Vein (PV), which then divides into the left and right
portal vein branches (LPV and RPV). The vessel parameters and average velocity
were obtained from literature results of which can be seen in Table 6. The model
parameters can be found in Table 7. Four variations of the geometry were investigated;
a planar model, 90-degree model, 45-degree model and an Altered 90-degree model.
The models can be seen in Figure 25. These models were created using GAMBIT
2.4.6.
Table 6: Literature Portal Vein Parameters
Vein Average Velocity (cm/s) Diameter (mm) Length (cm)






Table 7: Idealized Model Geometry Parameters
Vein Diameter (mm) Length (cm)





(a) Planar (b) 90-Degree
(c) 45-Degree (d) Altered 90-Degree
Figure 25: Idealized Model Geometries
5.2 Computational Analysis
5.2.1 Mesh Generation
GAMBIT 2.4.6 was used to generate a mesh for all models, the meshing parameters
are located in Table 8 and an example mesh for the Altered 90-degree Model is found
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in Figure 26
Table 8: Mesh Generation Parameters
Model Mesh Type Mesh Size Mesh Volume
Planar Tet/Hybrid 0.1 55,599
90-Degree Tet/Hybrid 0.1 53,205




Figure 26: Altered 90-Degree Model Mesh
5.2.2 Boundary Conditions
The boundary conditions used in all 4 models were a constant flat profile inlet velocity
for the SMV (0.21 m/s) and SV (0.18 m/s) and a flow split for the RPV (0.6) and
LPV (0.4), all taken from the literature.
5.2.3 Computations
The commercial code FLUENT was used to solve this 3D laminar, steady flow field.
All solutions reached convergence criteria within 81 iterations. In order to determine
that the outlets were of sufficient length as not to have an effect on the flow field, an
extended planar model was developed for comparison. This extended model showed
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little difference between the flow fields in the outlets and thus the extensions were
not necessary.
5.3 Planar Model
The computational results showed that the velocity along the portal vein is parabolic-
like with slight skewing to the posterior side of the PV closest to the confluence (Figure
27). There is also little mixing of the blood from the SV and SMV based upon close
to zero secondary velocities in the cross-sectional plane and streamtraces (Figures 28,
29 & 30). Both the LPV and RPV illustrate skewing of the velocity profile to the
inner walls which is consistent with bifurcating vessels (Figures 31 & 32).
Figure 27: Planar Model PV Cross-Sections; Velocity Magnitude m/s
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Figure 28: Planar Model PV Z-direction Velocity Magnitude m/s
Figure 29: Planar Model PV X-direction Velocity Magnitude m/s
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Figure 30: Planar Model Streamtraces
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Figure 31: Planar Model RPV Outlet Velocity Magnitude m/s
Figure 32: Planar Model LPV Outlet Velocity Magnitude m/s
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5.4 90-Degree Model
In this model, the outlets were rotated 90-degrees from the planar model. This
geometrical change did not affect the velocity profile within the portal vein (Figure
33). Little mixing of the SMV and SV blood is seen in the streamtraces (Figure 34).
The LPV and RPV velocity profiles also remain unchanged.
Figure 33: 90-Degree Model PV Cross-Sectional Velocity Magnitude m/s
Figure 34: 90-Degree Model PV Streamtraces
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5.5 45-Degree Model
In this model the outlets were rotated 45-degrees from the planar model. Again this
geometrical change did not affect the velocity profile within the portal vein (Figure
35). And again little mixing of the SMV and SV blood is seen with the streamtraces
(Figure 36). The LPV and RPV profiles also remain unchanged.
Figure 35: 45-Degree Model PV Cross-Sectional Velocity Magnitude m/s
Figure 36: 45-Degree Model PV Streamtraces
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5.6 Altered 90-Degree Model
For this model the angle between the PV and SMV was increased from that of the
previous 90-degree model. This geometrical change resulted in changes in the PV
cross-sectional velocity profile (Figure 37). However these changes disappeared by the
bifurcation allowing for similar RPV and LPV profiles as compared to the previous
models. At the center of the PV, the velocity profile is skewed to the superior wall
of the PV (Figure 38). Streamtraces again indicate little mixing of the blood (Figure
39).
Figure 37: Altered 90-Degree Model PV Cross-Sectional Velocity Magnitude m/s
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Figure 38: Altered 90-Degree Model Center PV Velocity Magnitude m/s
Figure 39: Altered 90-Degree Model Streamtraces
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5.7 Model Comparisons
The center PV cross-sectional velocity profile cross-sections for each model can be
seen in Figure 40. The first three are similar but the altered 90-degree model is
skewed a little more to the superior wall of the portal vein.
(a) Planar (b) 90-Degree
(c) 45-Degree (d) Altered 90-Degree
Figure 40: Idealized Model Center PV Cross-Sections Velocity Magnitude m/s
5.8 Flow Contribution Calculation
A protocol was developed to calculate the flow contributions of the SV to the right
and left PV and therefore the the contribution of the SMV to the RPV. This was
done for the altered 90-degree model. The results show 41% of splenic flow going to
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the LPV and 59% going to the RPV. However, the splenic flow accounts for 25% of
both the RPV and LPV flow. Thus the SMV flow contributes 75% to both the RPV
and LPV. The streamtraces show that the splenic flow is pushed towards the superior
wall of the PV. Results can be seen in Tables 9, 10 & 11 and Figures 41 & 42.






Table 10: Idealized CFD Calculated Flow Rate (ml/min)
SV to LPV 126.64
SV to RPV 179.54
Total SV 306.18






Figure 41: Idealized Model: Splenic vein cross-section showing which particles went
to the RPV (green) and LPV (red)
Figure 42: Idealized Model: Streamtraces for particles going to the LPV
57
5.9 Unsteady Calculations
Although preliminary data and the literature show that the PV flow has little varia-
tion and is basically steady, unsteady calculations were run to determine whether the
flow could be treated as quasisteady. Unsteady calculations were run using the altered
90-degree model. In order for the unsteady calculations to converge it was necessary
to add 3 cm to each outlet. A user defined function was created from PCMRI data
for the SV and SMV boundary conditions. Waveforms measured in subject N6 can
be seen in Figure 43.
Figure 43: Average Velocity SMV and SV Inlet Boundary Conditions from MR data
for subject N6
In the center of the PV the velocity remained slightly skewed to the superior side
of the PV throughout the cardiac cycle. The area of highest velocity increased and
decreased during the cardiac cycle. A sampling of center PV cross-sections at various
time points is found in Figure 44.
58
(a) t=0.063s (b) t=0.189s
(c) t=0.315s (d) t=0.441s
(e) t=0.567s (f) t=0.693s
(g) t=0.816s (h) t=0.945s
Figure 44: Idealized Unsteady Calculations: Center PV Cross-Sectional Velocity Mag-
nitude (m/s) at various time points; Color scale goes from 0.01 m/s to 0.13 m/s
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5.9.1 Quasisteady Check
Since there was little fluctuation in the inlet velocity boundary conditions a quasi-
steady check was performed. A comparison of the center PV cross-sectional velocity
magnitude profiles for steady and unsteady calculations at the same inlet velocities
was completed. As seen in Figure 45, there is little difference between the steady and
unsteady calculations, so that a quasisteady approach is applicable.
(a) Unsteady Flow (b) Steady Flow
Figure 45: Center PV Cross-Sectional Velocity Magnitude 7th time step m/s
5.10 Idealized Model Summary
The purpose of creating the idealized models was to become familiar with the char-
acteristics of portal venous flow and CFD starting with simplified models. The goal
was also to gain some insight into the affects of geometry and boundary conditions
on the CFD results. For all models, the flow in the PV was approximately parabolic
and there was little mixing of the blood from the two inlets. In the altered 90-degree,
the center PV velocity profile was also approximately parabolic but it was skewed
slightly more to the superior wall of the PV; however, this effect disappeared by the
bifurcation. The flow contribution protocol was developed and tested on the altered
90-degree model which illustrated that the SMV contributes to roughly 75% of both
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the RPV and LPV flows. This did not confirm the hypothesis that the SMV pri-
marily feeds the RPV. The quasisteady assumption was also assessed for the altered
90-degree model which showed some variation with time but when compared to the
steady counterpart there was minimal difference. Moving forward, these techniques
will be applied to both the normal subjects and the patients with more complex ge-
ometries. We postulate that the quasisteady assumption will also be valid for the
subject specific CFD models.
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CHAPTER VI
NORMAL PORTAL VENOUS HEMODYNAMICS
Specific Aim 2: Characterize hemodynamics in the normal adult portal venous
system.
6.1 MR Data Acquisition
The data set consisted of 9 normal volunteers, 4 males and 5 females, all ages 25-30
with no previously diagnosed liver disease.
6.1.1 Vessel Geometry
The geometry was successfully obtained in 7 subjects. General characteristics include
a straight PV, winding SV, and PV branch variations which can be seen in Figures
46, 47, and 48. There was generally a narrowing of the SMV before the PV confluence
due to the pancreas and the supine position of the subject. In addition in Figure 47
an SMV branch variation is also seen.
Figure 46: N1 Portal Vein Geometry
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Figure 47: N6 Portal Vein Geometry
Figure 48: N3 Portal Vein Geometry
6.1.2 Velocity Measurements
Velocity measurements were taken at the center cross-section of the PV, the SMV
and SV before the confluence, and either the RPV or LPV after the bifurcation but
before any branches, if possible. The measurement locations are marked by red lines
on Figure 48.
6.1.2.1 Portal Vein
The velocity was successfully obtained in 7 subjects. The velocity profiles were
parabolic-like although skewed. The direction of the skewing was dependent on the
subject. Center PV cross-sectional velocity profiles at time of maximum velocity can
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be seen in Figure 49.
PV area ranged from 0.879 - 1.1 cm2. There were little velocity and flow rate
changes over the cardiac cycle as seen in Figures 86 & 87. The average velocity was
12.74 cm/s and the average flow rate was 783 ml/min. Results for the PV can be
found in Table 12.














N0 14.4 4.16 848.8 227.9 0.924
N1 9.43 7.38 528.8 413.7 0.935
N3 9.55 2.99 558.3 180.6 0.919
N5 10.9 2.93 597.2 186.7 0.879
N6 16.4 4.67 1126.8 446.6 1.1
N8 17.03 5.15 1057.8 269.6 0.994
N9 11.5 3.61 766 178.2 1.07
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(a) N0 (b) N1
(c) N3 (d) N5
(e) N6 (f) N8
(g) N9
Figure 49: Normal Center PV Cross-sections displaying Velocity Magnitude (cm/s)
at maximum velocity and at the same anatomical orientation. Note that the spatial
and velocity scales differ among the figures.
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Figure 50: Normal Subject Average PV Cross-Sectional Velocity (cm/s)
Figure 51: Normal Subject Average PV Cross-Sectional Flow Rate (ml/min)
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6.1.2.2 Superior Mesenteric Vein
Velocity was successfully obtained in 6 subjects. Generally multiple jets were ob-
served, potentially due to SMV branches upstream. SMV cross-sectional velocity
profiles at the time of maximum velocity can be seen in Figure 52.
SMV area ranged from 0.361 - 0.966 cm2. The multiple jets can also be seen in
the SMV average velocity and flow rate waveforms (Figures 53 & 54). The average
velocity was 9.8 cm/s and the average flow rate was 386 ml/min. Note that subject
N8 had a high velocity but also a small area so that the flow was only slightly higher
than the other subjects. Continuity was maintained for this subject, therefore these
measurements are potentially reasonable. Results for the SMV can be found in Table
13.














N3 6.23 2.65 231 123.8 0.584
N4 6.46 2.71 332.3 143.9 0.855
N5 6.61 3.1 385.1 181.1 0.966
N6 6.8 2.03 394.2 123.1 0.902
N8 25.05 7.6 506.2 204.4 0.361
N9 7.64 2.85 410.1 223.2 0.791
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(a) N3 (b) N4
(c) N5 (d) N6
(e) N8 (f) N9
Figure 52: Normal SMV Cross-sections displaying Velocity Magnitude (cm/s) at time
of maximum velocity and at the same anatomical orientation. Note that the spatial
and velocity scales differ among the figures.
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Figure 53: Normal Subject Average SMV Cross-Sectional Velocity (cm/s)
Figure 54: Normal Subject Average SMV Cross-Sectional Flow Rate (ml/min)
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6.1.2.3 Splenic Vein
Velocity was successfully obtained in 7 subjects. Due to the winding nature of the
SV, skewed velocity profiles were seen. SV cross-sectional velocity profiles at the time
of maximum velocity can be seen in Figure 55.
SV area ranged from 0.443 - 0.742 cm2. Generally, only small variations were
seen in the velocity and flow rate waveforms (Figures 56 & 57). N8 had the largest
variation in waveforms. The average velocity was 7.93 cm/s and the average flow rate
was 300 ml/min. Results for the SV can be found in Table 14.














N1 6.19 3.16 203.5 159.5 0.548
N3 7.21 2.57 232.9 84.67 0.488
N4 10.53 1.48 477 64.88 0.742
N5 6.73 1.84 217.1 110.5 0.443
N6 6.64 1.59 269.5 80.97 0.626
N8 9.0 3.72 247.2 157 0.658
N9 8.65 3.61 329 178 0.553
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(a) N1 (b) N3
(c) N4 (d) N5
(e) N6
(f) N8 (g) N9
Figure 55: Normal SV Cross-sections displaying Velocity Magnitude (cm/s) at time
of maximum velocity and at the same anatomical orientation. Note that the spatial
and velocity scales differ among the figures.
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Figure 56: Normal Subject Average SV Cross-Sectional Velocity (cm/s)
Figure 57: Normal Subject Average SV Cross-Sectional Flow Rate (ml/min)
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6.1.2.4 Right Portal Vein
Velocity was successfully obtained in 4 subjects. The cross-sectional velocity profiles
were skewed as expected at a bifurcation. RPV cross-sectional velocity profiles at the
time of maximum velocity can be seen in Figure 58.
(a) N3 (b) N4
(c) N5 (d) N9
Figure 58: Normal RPV Cross-sections displaying Velocity Magnitude (cm/s) at time
of maximum velocity and at the same anatomical orientation. Note that the spatial
and velocity scales differ among the figures.
RPV area ranged from 0.684 - 1.23 cm2. Generally, very small variations were
seen in the velocity and flow rate waveforms (Figures 59 & 60). The average velocity
was 10.4 cm/s and the average flow rate was 606 ml/min. Results for the RPV can
be found in Table 15.
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Figure 59: Normal Subject Average RPV Cross-Sectional Velocity (cm/s)
Figure 60: Normal Subject Average RPV Cross-Sectional Flow Rate (ml/min)
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N3 9.67 1.53 518.7 114.9 0.87
N4 11.1 1.85 881.3 185.2 1.23
N5 10.86 3.92 479.5 269.7 0.684
N9 10 2.27 575 151.4 0.875
6.1.2.5 Portal Vein Flow Split
The flow split between the left and right portal vein branches was calculated and the
results are given in Table 16. This calculation was done by taking the ratio of average
RPV flow over the average PV flow the LPV flow was then the difference. The trend
in two of the three was for a greater percentage of blood to go to the RPV.
Table 16: Normal Flow Split




6.1.2.6 Portal Flow Compositions
The composition of portal vein flow was determined and the results can be seen in
Table 17. In all cases the results are consistent and the SMV blood composed a
majority of the PV blood.
6.2 Computational Models
In order to understand portal venous flow in greater detail, CFD was employed to
calculate the flow field for two of the normal subjects.
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Table 17: Normal PV Contributions







6.2.1 Normal Subject 3
In order to impose a parabolic velocity profile for the SMV and SV inlets, the inlets
were extended to allow the flow to develop. The outlets were also extended due to
the outflow impositions. Table 18 provides the extension and mesh details.






Mesh Interval 1 mm
No. Volumes 687237
6.2.1.1 Steady Flow Calculations
The boundary conditions were taken from the PC-MR data collected and can be
found in Table 19. Three different steady flow calculations were performed, one using
the average inlet velocities over the cardiac cycle, one using the inlet velocities at
maximum flow and one using the inlet velocities at minimum flow. The outflows are
prescribed as flow splits and remained constant. In this case, there were two unknown
outlets. Since they appeared to have roughly the same area, the flow was split evenly
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between them.
Table 19: N3 Steady Boundary Conditions (Velocities and Flow Divisions)
Average Values Max Flow Min Flow
SV (cm/s) 6.92 8.55 7
SMV (cm/s) 5.88 7.24 5.07
RPV 0.8 0.8 0.8
PRPV 0.1 0.1 0.1
LPV 0.1 0.1 0.1
For the average velocity case, the flow at the center of the PV was approximately
parabolic although slightly skewed to the anterior side. The maximum and minimum
flow cases illustrated the same skewing. Center PV cross-sectional velocity profiles at
the time of maximum velocity can be seen in Figure 61.
There was evidence of modest mixing of the blood from the SMV and SV, as





Figure 61: N3 Steady CFD PV Cross-sections displaying Velocity Magnitude (m/s)
at the same anatomical orientation
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Figure 62: N3 Steady CFD Average Streamtraces; SMV (blue) and SV (red).
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6.2.1.2 Flow Contribution Calculations
The flow contribution of blood from the SMV to the right and left portal veins
was calculated and results can be found in Table 20. The streamtraces show the
movement of the fluid towards the outlets (Figure 63). A visual representation of
the SMV cross-section shows which streamlines went to which corresponding outlet
(Figure 64). SMV blood is the major contributor to the RPV and LPV contributing
to 91% of the RPV flow, 96% to the LPV and 21% to the Posterior-RPV. A total of
95% of the SMV blood went to a RPV branch.
Table 20: N3 Flow Contributions













Figure 63: N3 Flow Contribution Streamtraces; RPV (red), PRPV (yellow) and LPV
(Green)
Figure 64: N3 SMV Cross-Section illustrating Flow Contributions
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6.2.1.3 Unsteady Flow Calculations
Although there were slight variations in the velocity and flow over the cardiac cycle,
unsteady calculations were performed to assess the validity of assuming quasisteady
flow. The velocity and flow for N3 from the MR data are found in Figures 65 and 66.
Figure 65: N3 Inlet Velocities (cm/s)
Figure 66: N3 Flow Rate (ml/min)
The inlet velocities for the SMV and SV were used as the boundary conditions
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for the unsteady calculations. The center PV velocity magnitude cross-sections were
similar to the steady flow calculations done at maximum and minimum flow. A
comparison of the cross-sections can be found in Figures 67 & 68. The maximum
unsteady case had a similar magnitude and profile as the steady case. The minimum
unsteady case had slightly lower velocity magnitudes and a different skewing pattern.
(a) Unsteady Max Flow (b) Steady Max Flow
Figure 67: Unsteady Calculations Comparison: PV Cross-sections displaying Velocity
Magnitude (m/s)Note: Different Color Scale
(a) Unsteady Min Flow (b) Steady Min Flow
Figure 68: Unsteady Calculations Comparison: PV Cross-sections displaying Velocity
Magnitude (m/s)Note: Different Color Scale
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6.2.1.4 N3 Validation
To validate the model the CFD results were compared to the MR results. Although
the MR images were not taken exactly perpendicular to the vessel axis, the skewing,
area of high velocity, and magnitude are similar as evidenced by Figure 69.
(a) Average Steady Flow (b) Average MR
Figure 69: N3 PV Cross-Sections comparing Average CFD Result to MR Data
The results for maximum flow and minimum flow were also compared with their
MR counterparts, and again the velocity profile and magnitude compared favorably.
The comparisons can be seen in Figures 70 and 71.
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(a) Max Flow (b) MR Data Time Point 7
Figure 70: N3 PV Cross-Sections comparing Max Flow Unsteady CFD Result to MR
Data
(a) Min Flow (b) MR Data Time Point 2
Figure 71: N3 PV Cross-Sections comparing Min Flow Unsteady CFD Result to MR
Data
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6.2.2 Normal Subject 9
The SMV and SV inlets were again extended to allow the flow to develop. The outlets
were also extended due to the outflow impositions. Table 21 provides the extension
and mesh details.





Mesh Interval 1 mm
No. Volumes 727225
6.2.2.1 Steady Flow Calculations
The boundary conditions were taken from the PC-MR data collected and can be
found in Table 22. The inlet velocities were the average velocities over the cardiac
cycle. The outflows are prescribed as flow splits and remained constant.






The velocity at the center of the PV was skewed to the posterior side. A center PV
cross-sectional profile of velocity magnitude can be seen in Figure 72. The stream-
traces showed greater mixing of the blood than N3 and also some rotation (Figure
73).
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Figure 72: N9 Center PV Cross-Sections Velocity Magnitude (m/s)
Figure 73: N9 Streamtraces; SMV (blue), SV (red).
6.2.2.2 Flow Contribution Calculations
The flow contribution of blood from the SMV to the right and left portal veins was
calculated and results can be found in Table 23. 26% of the SMV blood went to the
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LPV and 63% went to the RPV thus the majority of the SMV flow did go to the RPV.
LPV blood is composed of 94% SMV blood and RPV blood is composed of 48% SMV
blood. Even though the majority of the SMV flow supplies the RPV, the SMV is
the major contributor to the LPV. The streamtraces show the movement of the fluid
towards the outlets (Figure 74). A visual representation of the SMV cross-section
shows which streamlines went to which corresponding outlet (Figure 75).
Table 23: N9 Flow Contributions










6.2.2.3 Unsteady Flow Calculations
Again, quasisteady flow was assessed and unsteady calculations run. The velocity
and flow for N9 from the MR data are found in Figures 76 and 77.
The inlet velocities for the SMV and SV were used as the boundary conditions
for the unsteady calculations. The unsteady cross-sectional velocity profile at a time
point (time point 8) with similar inlet velocities to the average steady case was com-
pared to the steady case (Figure 78). The magnitude was similar to the steady
calculations but the skewing was a little more inferior. Even with these differences,
quasisteady flow may still be applicable.
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Figure 74: N9 Flow Contribution Streamtraces; RPV (red) and LPV (green).
Figure 75: N9 SMV Cross-Section illustrating Flow Contributions
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Figure 76: N9 Inlet Velocities (cm/s)
Figure 77: N9 Flow Rate (ml/min)
90
(a) Unsteady Time Point 8 (b) Average Steady Flow
Figure 78: N9 Unsteady PV Cross-Section Velocity Magnitude (m/s)
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6.2.2.4 Validation
To validate the model the CFD results were compared to the MR results. The MR
data shows a more centered parabolic-like profile while the CFD data shows a slight
skewing to the posterior side. The velocity magnitudes are slightly lower in the CFD
results for all cases. Unsteady CFD results were compared with the MR data from the
same time step, including average, maximum, and minimum flow. These comparisons
can be seen in Figures 79, 80, and 81.
(a) Average Unsteady Flow Time Step 8 (b) Average MR Time Step 8
Figure 79: N9 PV Cross-Sections comparing Unsteady Average CFD Result to MR
Data; Note: Different Scales
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(a) Unsteady Max Flow Time Step 17 (b) MR Data Time Point 17
Figure 80: N9 PV Cross-Sections comparing Max Flow Unsteady CFD Result to MR
Data; Note: Different Scales
(a) Unsteady Min Flow Time Step 7 (b) MR Data Time Point 7
Figure 81: N9 PV Cross-Sections comparing Min Flow Unsteady CFD Result to MR
Data; Note: Different Scales
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CHAPTER VII
PATIENT PORTAL VENOUS HEMODYNAMICS
Specific Aim 3: Characterize hemodynamics in the portal venous system in patients
with cirrhosis and portal hypertension.
7.1 MR Data Acquisition
The data set includes 4 patients who were already scheduled for an abdominal MRI
with a diagnosis of cirrhosis. All subjects had more advanced cirrhosis. A summary
of cirrhosis indicators for each patient can be found in Table 24
Table 24: Patient Cirrhosis Characteristics from MR
Parameter D2 D4 D5 D6
Sex M M F F
Fibrosis Moderate Mod-Severe Diffuse Moderate Mode-Severe Diffuse
Inflammation Moderate Minimal Moderate Moderate
Varices Mild Mild Moderate (no SV) Moderate
Acites No No No Trace
Tumor No No No No
PV Thrombosis No No No No
Spleen Enlargement Severe Marked Mild Severe
7.1.1 Vessel Geometry
The geometry was successfully obtained in 3 subjects. Again the PV is fairly straight
and different PV branch variations are seen, including a trifurcation in Figure 82. In
D5 the splenic vein no longer exists, it has been replaced by a varice or shunt (Figure
83).
94
Figure 82: D4 Portal Vein Geometry
Figure 83: D5 Portal Vein Geometry
Figure 84: D6 Portal Vein Geometry
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7.1.2 Velocity Measurements
The velocity measurements were taken at the same location as for the normal subjects-
please refer to Figure 48 on page 63.
7.1.2.1 Portal Vein
The velocity was successfully obtained in 4 subjects. Some patients had skewed
parabolic-like profiles while others showed multiple jets. The direction of the skewing
was always to the posterior inferior side of the PV. Center PV cross-sectional velocity
profiles at the time of maximum velocity can be seen in Figure 85.
(a) D2 (b) D4
(c) D5 (d) D6
Figure 85: Patient PV Cross-sections displaying Velocity Magnitude (cm/s) at time
of maximum velocity and at the same anatomical orientation. Note that the spatial
and velocity scales differ among the figures.
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PV area ranged from 1.35 - 2.41 cm2. There were little velocity and flow rate
changes over the cardiac cycle as seen in Figures 86 and 87. Note the lower velocity
and flow in D5 which had no SV and a small SMV. The average velocity was 8.45
cm/s and the average flow rate was 1048 ml/min. Results for the PV can be found
in Table 25.
Figure 86: Patient Average PV Cross-Sectional Velocity (cm/s)
Figure 87: Patient Average PV Cross-Sectional Flow Rate (ml/min)
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D2 11.68 2.54 1788 424 2.41
D4 8.97 0.99 959 106 1.7
D5 4.28 3.12 363 265 1.35
D6 8.45 1.66 1080 204 1.88
7.1.2.2 Superior Mesenteric Vein
Velocity was successfully obtained in 3 subjects. The velocity profile was mainly
centered and parabolic-like but reverse velocities were seen in one subject perhaps due
to upstream varices. SMV cross-sectional velocity profiles at the time of maximum
velocity can be seen in Figures 88.
SMV area ranged from 0.8 - 1.83 cm2. There was some variation in the SMV
average velocity and flow rate waveforms (Figures 89 & 90). The average velocity
was 4.97 cm/s and the average flow rate was 394 ml/min. Results for the SMV can
be found in Table 26.














D4 7.89 1.76 620 141 1.21
D5 4.18 2.76 263 174 0.8
D6 2.98 1.81 327 198 1.83
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(a) D4 (b) D5
(c) D6
Figure 88: Patient SMV Cross-sections displaying Velocity Magnitude (cm/s) at time
of maximum velocity and at the same anatomical orientation. Note that the spatial
and velocity scales differ among the figures.
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Figure 89: Patient Average SMV Cross-Sectional Velocity (cm/s)
Figure 90: Patient Average SMV Cross-Sectional Flow Rate (ml/min)
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7.1.2.3 Splenic Vein
Velocity was successfully obtained in 4 subjects. Due to the winding nature of the
SV, skewed velocity profiles were seen. SV cross-sectional velocity profiles at the time
of maximum velocity can be seen in Figure 91. Subjects D2 and D4 had areas of low
velocity and contained some noise that could not be filtered out. The D5 SV profile
represents the shunt.
(a) D2 (b) D4
(c) D5 (d) D6
Figure 91: Patient SV Cross-sections displaying Velocity Magnitude (cm/s) at time
of maximum velocity and at the same anatomical orientation. Note that the spatial
and velocity scales differ among the figures.
SV area ranged from 0.834 - 1.7 cm2. Generally little variations were seen in the
velocity and flow rate waveforms (Figures 92 & 93). D2 had the largest variation in
waveforms. The average velocity was 8.88 cm/s and the average flow rate was 666
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ml/min. Results for the SV can be found in Table 27.
Figure 92: Patient Average SV Cross-Sectional Velocity (cm/s)
Figure 93: Patient Average SV Cross-Sectional Flow Rate (ml/min)
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D2 10.8 3.7 1108 378 1.7
D4 6.89 3.21 449 193 1.06
D5 8.35 1.47 430 88 0.834
D6 9.52 1.17 685 75 1.14
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7.1.2.4 Right and Left Portal Vein
Velocity was successfully obtained in one subject for the RPV and in one other sub-
ject for the LPV. The cross-sectional velocity profiles were skewed as expected at a
bifurcation. RPV cross-sectional velocity profile at the time of maximum velocity can
be seen in Figure 94 and LPV cross-sectional velocity profile at the time of maximum
velocity can be seen in Figure 95.
Figure 94: Patient (D6) Average RPV Cross-Sectional Velocity (cm/s)
Figure 95: Patient (D4) Average LPV Cross-Sectional Velocity (cm/s)
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The RPV area was 1.15 cm2 and the LPV area was 0.5 cm2. Generally, little
variations were seen in the velocity and flow rate waveforms (Figures 96 & 97). The
average velocity was 8.32 cm/s and the average flow rate was 603 ml/min for the
RPV and 8.56 cm/s and 267 ml/min for the LPV. Results for the R/LPV can be
found in Table 28.
Figure 96: Patient Average R/LPV Cross-Sectional Velocity (cm/s)
















8.56 2.45 267 75 0.5
D6
(RPV)
8.32 1.93 603 128 1.15
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Figure 97: patient average R/LPV Cross-Sectional Flow Rate (ml/min)
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7.1.2.5 Portal Vein Flow Split
The flow split between the left and right portal vein branches was calculated and the
results are in Table 29. The flow to the RPV was greater than the flow to the LPV.
Table 29: Patient Flow Split
Subject Flow Split (RPV/LPV)
D4 0.72/0.28
D6 0.56/0.44
7.1.2.6 Portal Flow Compositions
The composition of portal vein flow was determined and the results can be seen in
Table 30. In two out of the three subjects the SMV contributed more than the SV.
Table 30: Patient PV Contributions





In order to understand cirrhotic portal venous flow in greater detail, CFD was em-
ployed to calculate the flow field for two of the patients.
7.2.1 Patient 4
In order to impose a parabolic flow profile for the SMV and SV inlets, the inlets were
extended to allow the flow to develop. The outlets were also extended due to the
outflow impositions. Table 31 provides the extension and mesh details.
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Mesh Interval 1 mm
No. Volumes 1,717,255
Table 32: D4 Steady Boundary Conditions (Velocities and Flow Division)
Average Values Max Flow Min Flow
SV (cm/s) 6.89 8.01 5.26
SMV (cm/s) 7.76 8.21 6.98
RPV 0.36 0.36 0.36
ARPV 0.36 0.36 0.36
LPV 0.28 0.28 0.28
7.2.1.1 Steady Flow Calculations
The boundary conditions were taken from the PC-MR data collected and can be
found in Table 32. Three different steady flow calculations were performed, one using
the average inlet velocities over the cardiac cycle, one using the inlet velocities at
maximum flow and one using the inlet velocities at minimum flow. The outflows are
prescribed as flow splits and remained constant.
For the average case, the flow at the center of the PV was parabolic-like with
skewing towards the inferior posterior side. There was evidence of modest mixing of
the blood from the SMV and SV, as evidenced by plots of streamlines (Figure 98).
The maximum and minimum flow cases illustrated the same skewing. Center PV
cross-sectional velocity profiles can be seen in Figure 99.
108





Figure 99: D4 Steady CFD PV Cross-sections displaying Velocity Magnitude (m/s)
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7.2.1.2 Flow Contribution Calculations
The flow contribution of blood from the SMV to the right and left portal veins was
calculated and results can be found in Table 33. SMV blood composes 37% of the
RPV flow and 99% of the LPV flow. 53% of the SMV blood went to the LPV.
The streamtraces show the movement of the fluid towards the outlets (Figure 100).
A visual representation of the SMV cross-section shows which streamlines went to
which corresponding outlet (Figure 101).
Table 33: D4 Flow Contributions












Figure 100: D4 Flow Contribution Streamtraces: LPV (green) and RPV (red).
Figure 101: D4 SMV Cross-Section illustrating Flow Contributions
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7.2.1.3 Unsteady Flow Calculations
Unsteady calculations were not performed for this subject.
7.2.1.4 D4 Validation
To validate the model the CFD results were compared to the MR results. Although
there was noise present in the MR images, the areas of high velocity and magnitude
are approximately similar as evidence by Figure 102. The CFD result was also com-
pared to the cross-sectionally averaged MR PV image and again compared favorably
although in the MR images the area of high velocity extends towards the posterior
superior side verses the anterior superior side.
(a) Average Steady Flow (b) Average MR Time Point 2
(c) Cross-Sectionally Averaged MR
Figure 102: D4 PV Cross-Sections comparing Average CFD Result to MR Data
The results for maximum flow and minimum flow were also compared with their
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MR counterparts, and again the magnitude compares favorably although for the
maximum flow, one area of high velocity was not captured in the CFD model. The
comparisons can be seen in Figures 103 and 104.
(a) Max Flow (b) MR Data Time Point 6
Figure 103: D4 PV Cross-Sections comparing Max Flow Steady CFD Result to MR
Data
(a) Min Flow (b) MR Data Time Point 15
Figure 104: D4 PV Cross-Sections comparing Min Flow Steady CFD Result to MR
Data
7.2.2 Patient 6
In order to impose a parabolic flow profile for the SMV and SV inlets, the inlets were
extended to allow the flow to develop. The outlets were also extended due to the
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outflow impositions. Table 34 provides the extension and mesh details.





Mesh Interval 1 mm
No. Volumes 1,158,591
7.2.2.1 Steady Flow Calculations
The boundary condition were taken from the PC-MR data collected and can be
found in Table 35. Three different steady flow calculations were performed, one using
the average inlet velocities over the cardiac cycle, one using the inlet velocities at
maximum flow and one using the inlet velocities at minimum flow. The outflows are
prescribed as flow splits and remained constant.
Table 35: D6 Steady Boundary Conditions (Velocities and Flow Division)
Average Values Max Flow Min Flow
SV (cm/s) 9.52 9.76 8.96
SMV (cm/s) 2.98 3.53 2.62
RPV 0.56 0.56 0.56
LPV 0.44 0.44 0.44
For the average case, the flow at the center of the PV was heavily skewed towards
the inferior anterior side. There was evidence of mixing of the blood from the SMV
and SV, as evidenced by plots of streamlines (Figure 105). Also note the rotation
in the flow. The maximum and minimum flow cases illustrated the same skewing.
Center PV cross-sections of Velocity Magnitude can be seen in Figure 106.
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Figure 106: D6 PV Cross-sections displaying Velocity Magnitude (m/s) at same
anatomical orientation
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7.2.2.2 Flow Contribution Calculations
The flow contribution of blood from the SMV to the right and left portal veins was
calculated and results can be found in Table 36. The SMV contributes 7% of the
RPV flow and 13% of the LPV. Therefore the outlets are mainly fed by the SV. 59%
of the SMV blood goes to the LPV. The streamtraces show the movement of the fluid
towards the outlets (Figure 107). A visual representation of the SMV cross-section
shows which streamlines went to which corresponding outlet (Figure 108).
Table 36: D6 Flow Contributions











Figure 107: D6 Flow Contribution Streamtraces: RPV (red) and LPV (green).
Figure 108: D6 SMV Cross-Section illustrating Flow Contributions
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7.2.2.3 Unsteady Flow Calculations
Although there were slight variations in the velocity and flow over the cardiac cycle,
unsteady calculations were performed to assess the validity of quasisteady flow. The
velocity and flow for D6 from the MR data are presented in Figures 109 and 110.
Figure 109: D6 Inlet Velocities (cm/s)
Figure 110: D6 Flow Rate (ml/min)
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The inlet velocities for the SMV and SV were used as the boundary conditions
for the unsteady calculations. The center PV velocity magnitude cross-sections were
similar to the steady flow calculations done at maximum and minimum flow. The
cross-sections can be found in Figures 111 & 112. Due to the similar magnitude of
velocity and shape of the profile, quasisteady flow is valid in this case.
(a) Unsteady Max Flow (b) Steady Max Flow
Figure 111: D6 Maximum Unsteady Calculations: PV Cross-sections displaying Ve-
locity Magnitude (m/s)
(a) Unsteady Min Flow (b) Steady Min Flow




To validate the model the CFD results were compared to the MR results. The mag-
nitude is lower and the direction of skewing is also not similar. In examining the di-
rection of skewing as you travel along the PV in the steady CFD results, the skewing
does change directions going to the posterior inferior side versus the inferior anterior
side of the PV. The comparison can be seen in Figure 113.
(a) Average Unsteady Flow (b) Average MR Time Point 11
Figure 113: D6 PV Cross-Sections comparing Average CFD Result to MR Data
The results for maximum flow and minimum flow were also compared with their
MR counterpart. And again the magnitude is lower in the minimum flow case, but
similar in the maximum flow case. In both cases the direction of skewing is not
similar. The comparisons can be seen in Figures 114 and 115.
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(a) Max Flow (b) MR Data Time Point 18
Figure 114: D6 PV Cross-Sections comparing Max Flow Unsteady CFD Result to
MR Data
(a) Min Flow (b) MR Data Time Point 12




COMPARISON OF PORTAL VENOUS HEMODYNAMICS
IN NORMAL SUBJECTS AND PATIENTS
Specific Aim 4: Identify differences in hemodynamic characteristics of the portal
venous system between normal.
Due to the limited number of subjects in this study these results are preliminary
and are not meant to fully characterize all normal subjects and patients but to lay
the foundation for the application of this methodology, initial findings and further
research.
8.1 Liver Volume
The patients had a larger average liver volume but the results were insignificant as
seen in Table 37. While the liver may enlarge initially in cirrhosis, as the disease
develops the right lobes may hypotrophy and the left lobe may hypertrophy, thus
calculating the volume per lobe may be an interesting addition.





Average (cm3) 1350 ±320 1559 ±676 0.595
8.2 Portal Vein
The PV area was significantly different for normals and patients. The PV area in-
creased which is in agreement with the literature findings. The range of values for the
area, velocity, and flow rate are within the ranges from literature. The parameters
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per liver volume were calculated in an effort to separate changes in velocity and flow
due to disease or due to increased liver mass, this has not been done previously to the
knowledge of the author. The velocity per liver volume was significantly decreased
in the patients. The velocity variance, perhaps an indicator of pulsatility, was signif-
icantly decreased in patients and is illustrated in the velocity graphs on pages 66 &
97. The lower velocity variance in patients may imply a steadier flow. In addition to
these significantly different parameters, the PV average velocity and the proportion
of SV blood in the PV were almost significantly different with the average velocity
decreased and SV/PV increased in patients. This is also in agreement with the lit-
erature. In comparing the velocity profile cross-sections the patients all had skewing
toward the lower posterior side while the normal subject skewing was variable. The
comparison results can be seen in Table 38.
Table 38: Portal Vein Comparison
Normal Patient p-value
Number of Subjects 7 4
Average Area (cm2) 0.97 ±0.08 1.75 ±3.09 0.048
Average Velocity
(cm/s)
12.74 ±3.17 8.74 ±3.09 0.083
Average Flow Rate
(ml/min)
783 ±241 1032 ±586 0.47
Number of Subjects 6 4
Ave Vel/Liver Vol-
ume
0.01 ±0.0025 0.0058 ±0.0017 0.002
Ave FR/Liver Vol-
ume
0.58 ±0.18 0.64 ±0.187 0.64
Vel Variance 4.4 ±1.7 1.93 ±1 0.02
Flow Variance 285 ±117 228 ±148 0.54
SV/PV 0.36 ±0.069 0.74 ±0.32 0.07
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8.3 Superior Mesenteric Vein
The superior mesenteric vein (SMV) has been under-investigated in patients except in
the evaluation of changes after a meal. While no results were significant, the general
trends were for the patients to have a larger area and a lower average velocity and
average velocity per liver volume. The values for area are within the literature range,
but the velocities were lower than the limited reportings in literature. This could be
due to the timing of exams in relation to meal time, since the SMV flow increases
after a meal. There was agreement with one study for the velocity but the study
showed a higher area and flow rate [26]. Further investigation is needed for the SMV
and perhaps more quantitative pre- and post-prandial studies including comparisons
with patients. The comparison results can be seen in Table 39.
Table 39: SMV Comparison
Normal Patient p-value
Number of Subjects 6 3
Average Area (cm2) 0.74 ±0.23 1.27 ±0.53 0.22
Average Velocity
(cm/s)
9.8 ±7.49 4.97 ±2.49 0.2
Average Flow Rate
(ml/min)
386 ±109 394 ±197 0.97
Number of Subjects 5 3
Ave Vel/Liver Vol-
ume
0.007 ±0.005 0.004 ±0.0017 0.23
Ave FR/Liver Vol-
ume
0.288 ±0.1 0.209 ±0.18 0.54
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8.4 Splenic Vein
Literature provides no consensus on the changes, if any, to the SV velocity. This
work illustrates a significant increase in SV area (agreement with literature) with
trends of an increase in velocity (not significant) and an increase in flow rate (almost
significant). However when the flow rate is taken per liver volume the results do
become significant. The magnitude of velocity was lower than literature predicted
but the flow rates were within range for both populations. Due to the significant
results this vein requires further investigation and attention. The comparison results
can be seen in Table 40.







0.578 ±0.1 1.18 ±0.37 0.043
Average Veloc-
ity (cm/s)










0.0057 ±0.001 0.0068 ±0.003 0.60
Ave FR/Liver
Volume
0.202 ±0.033 0.46 ±0.163 0.049
127
8.5 Right or Left Portal Vein
While no result was significant, perhaps due to the small number of subjects who were
successfully imaged, the trend seemed to be for the patients to have a lower RPV flow
split. This is consistent with increased resistance on the right side of the liver. The
trend was also for a smaller ratio of SMV blood in the RPV which could be related to
the overall flow reduction to the RPV as supported by literature. Another important
question is why was data acquisition unsuccessful in so many subjects. This was
partially due to the variable branching patterns and the need to capture data before
any branches. Defining a perpendicular slice through a section of the RPV to acquire
data also proved to be difficult. The comparison results can be seen in Table 41.









SMV/RPV 0.6 ±0.24 0.37 ±0.03 0.4
8.6 Individual Patient Comparisons
In addition to the lumped comparisons above, the patients were compared in a few
parameters individually with normal subject averages. The first parameter investi-
gated was PV velocity in Figure 116. Each normal subject and patient is plotted
separately and horizontal lines show the normal and patient averages and average
plus or minus a standard deviation. One patient D5 is far below the normal and
patient average. This particular patient had moderate varices, which means blood
was shunted from the PV, mild spleen enlargement, which means there was less of
an increase in splenic venous return, and no SV, the SV was replaced by a shunt also
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indicating low splenic venous return.
The next parameter was PV flow rate. Figure 117 plots the values for all subjects.
One patient, D2, had an increased PV flow rate when compared to both averages and
D5 had a relatively decreased flow rate in comparison. D2 presented with severe
spleen enlargement, thus increased splenic return, and mild varices, indicating that
only small amounts of blood were being shunted from the PV. These two classifications
together would present as increased PV flow. D5, as mentioned above, had no SV,
which is presumably the reason for the reduced PV flow.
Individual comparisons of the PV flow rate per liver volume showed some interest-
ing results (Figure 118). Since D2 has such increased flow, this patient was expected
to have increased flow rate per liver volume which indeed was true. However, D6 also
showed increased flow rate per liver volume. The complication that both of these
patients had was severe spleen enlargement. Patients D4 and D5 who had decreased
flow rate per liver volume showed only marked and mild spleen enlargement.
The last parameter is SMV flow rate as seen in Figure 119. While the normal and
patient averages were similar, patient D4 showed an increase in SMV flow. D4 had
only minimal inflammation which would provide less resistance to flow or the patient
had recently eaten temporarily increasing flow. The other two patients D5 and D6
had moderate varices which in addition to shunting blood from the PV can shunt
blood from the SMV as well. However the normal subjects also presented in a wide








































































































































Although there are only two normal models and two patient models, some preliminary
conclusions include increased rotation and secondary flow in the patients as compared
with the normal subjects. The streamlining theory held true for the normal subjects
but in the patients the streamlines rotated. While MR will be most clinically useful,
the CFD models supplement the MR data and provide information on streamlining
and blood tracking to the outlets.
8.8 Comparison Summary
Even with the limited number of subjects a few parameters were significant. Patients
with cirrhosis had a significantly increased PV area and a significantly decreased
average velocity per liver volume and velocity variance. Patients with cirrhosis had
a significantly increased SV area and average flow rate per liver volume. While these
results are preliminary due to small sample size, they are promising and require further
investigation and more subjects including varying stages of disease. In addition most
of the parameters had values that were within the ranges reported by literature,




The development of an idealized model allowed for an initial adaptation of CFD
methodology to the portal venous system. The only geometric change that affected
the flow in the PV was the altered 90-degree model which increases the angle between
the PV and SMV. The flow within the portal vein was parabolic-like although slightly
skewed to the superior side of the PV. However, this pattern shifted to a more centered
parabolic-like flow by the bifurcation. There was little mixing of the blood from
the SMV and SV as evidenced by the streamtraces and nearly zero cross-sectional
velocities. This was as previous research suggested. A program was also developed
to calculate the contribution of an inlet flow to the outlets. There is some error in
this method as the velocities were multiplied by the grid area. For this aim the blood
from the SV was followed and percentages obtained for the two outlets. The results
showed that the SMV contributed 75% of the RPV and LPV flow, which supports the
hypothesis that the SMV mainly supplies the RPV. Also, unsteady calculations were
run in order to evaluate whether the flow was quasisteady. In the idealized model case
the quasisteady assumption held, which was promising for subject specific modeling.
The idealized model demonstrated the feasibility of conducting a CFD analysis
on the portal venous system. The results were as expected from literature. While
human portal vein geometries are more complex than the idealized models, we believe
that in moving forward to subject specific models this work allows us to postulate
that the velocity profiles within the PV will be parabolic-like with little mixing of the
blood and that the quasisteady flow assumptions will be valid.
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Normal subject volunteer data were collected after the method of MR data acqui-
sition was optimized allowing viable results to be gathered. Geometric variations were
observed as had been expected from the literature. Of note is a general anatomical
narrowing of the SMV before the PV confluence. We believe this to be due to the
pancreas and the supine position of the patient. For the PV the velocity profile was
skewed, although in no preferential direction, with an average velocity of 12.74 cm/s
and average flow rate of 783 ml/min. Thus, we believe that there is not a standard
skewing direction within the PV and that the direction is largely dependent on the
geometry. There was some variation in the velocity and flow rate waveforms. This
variation could be a product of the error inherent in the PC-MR acquisition method.
The SMV profiles showed a range from parabolic-like to jet-like characteristics, with
an average velocity of 9.8 cm/s and average flow rate of 386 ml/min. The SV profiles
were parabolic-like but skewed as were the RPV profiles. In all vessels the skewing
appears to be the result of the geometry orientation. The PV area was fairly consis-
tent across the normal population. The SMV velocity in subject N8 was over 200%
greater than the average velocity. However, when you look at the area of N8’s SMV,
it was much smaller than the average, thus the flowrate was in line with the other
subjects. The RPV/LPV flow split confirmed that the majority of the PV flow feeds
the RPV which supplies the right, larger, lobe of the liver. Another consistent result
was the composition of the PV blood. The SMV composed the majority of the PV
flow.
The MR data provided sufficient boundary conditions to create subject specific
converging CFD models. In both cases the PV velocity profile was parabolic-like
but the skewing was subject specific. This was the trend for the normal MR data.
There was little mixing of blood within the PV although N9 illustrated slightly more
mixing than N3 and also some rotation. One explanation is that N9 had a larger
angle between the SMV and SV than N3. In both cases the quasi-steady assumption
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was valid. In both cases the majority (95% for N3 and 63% for N9) of the SMV blood
ultimately goes to the RPV. For the N3 case, the SMV composed 84% of the RPV
flow and for N9 the SMV composed only 48% of the RPV flow. This difference could
be the result of anatomical differences in the veins as the LPV in N3 was very small
and most likely branches from the RPV fed portions of the LPV. We believe these
calculations to be important as the hypothesis is that liver disease is preferentially
located on the right side due to the SMV contribution to the RPV. While these data
do not prove the hypothesis, they do support it. Although the validation slices for
N3 were not taken exactly perpendicular to the vessel, the velocity profile skewing
was similar in both subjects. The velocity magnitude was approximately similar in
N3 and slightly lower in N9 when compared to the MR data. Thus, we believe the
CFD models to be validated, keeping in mind the accuracy of the MR measurements.
All patients in the study had moderately-advanced to advanced cirrhosis. Again
geometry variations were as expected although the narrowing of the SMV from the
pancreas appeared to be less pronounced. Perhaps that may reflect a higher pressure
in the vessel or stiffening of the vein. For the PV the direction of skewing was always
to the posterior side of the PV. There was also little velocity variation in the PV. For
the SMV the flow was parabolic-like, and reverse flow was seen in one subject perhaps
due to varices. The SV was difficult to image in some subjects and not all data were
of high quality. Generally, the flow was skewed and parabolic-like. In one case the
SV had disappeared entirely, replaced by a shunt. The RPV or LPV was difficult
to capture. For the one RPV case the flow was parabolic-like and for the LPV case
the image was not quite perpendicular to the vessel but otherwise the profile was
parabolic-like. Due to the range of disease states the results were not as consistent
as the normal subjects.
Again the MR data provided sufficient boundary conditions to create two subject
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specific converging CFD models. The D4 computational model showed skewing to-
wards the inferior posterior side of the PV that did not change under maximum or
minimum flow conditions. D6 model data showed skewing towards the inferior side
of the PV. These skewing results differ slightly from the trend seen in the MR data.
There was modest mixing of the blood in D4 with more rotation than was seen in the
normal subjects. In D6 there was definitely mixing of the blood and rotational flow.
The angle between the SMV and SV was large, almost 180 degrees. The quasi-steady
assumption is also valid for both cases. The majority of the SMV blood ( 53% for
D4 and 59% for D6) went to the LPV. For D4 the SMV composed 99% of the LPV
and only 37% of the RPV. For D6, the SMV composed 13% of the LPV and 7% of
the RPV. D6 had a very small SMV contribution in general. When CFD results were
compared with the MR images, the areas of high velocity matched although there
was noise in the D4 MR images. For D6, in comparing the CFD results to the MR
images the magnitudes were similar but the areas of high velocity were not. However
in additional slices from the CFD results, the center of high velocity shifted from the
anterior side to the posterior side. While the quality of patient MR data was less
than for the normal subjects, we believe it was sufficient to allow the CFD models
to represent the in vivo flow again allowing for errors inherent in the measurement
method.
We must preface this section by saying that while we feel that the number of
normal subjects is sufficient to provide average normal values, we recognize that
our pool of patients is small and limited and the comparisons drawn are meant to
be preliminary and represent areas for further research. In looking for anatomical
differences between the two groups the architecture of the liver tissue was obviously
different and has been documented elsewhere in literature. However, there was no
statistical difference in liver volume. This could be due to the fact that with cirrhosis
the liver may increase in size but then as the disease progresses the right lobe may
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hypotropy and the left lobe may hypertrophy maintaining a relatively normal liver
volume. It may be interesting to calculate the volume per liver lobe and map the
changes as the disease progresses. Other anatomical differences include a significantly
larger PV and SV area in patients as compared to normal subjects. The PV enlarges
due to the increase in pressure and the SV enlarges due to the increased blood supply
to the spleen and ultimately the SV.
In order to tease out whether differences in velocity were true or due to the
volume of the liver, we calculated velocity per liver volume values. While the PV
velocity was decreased in patients it was not statistically significant, however, the PV
velocity per liver volume was significantly lower in patients than in normals. Also,
the velocity variance was significantly lower in patients indicating near steady flow or
possibly variations due to measurement error. The SV flow rate per liver volume was
significantly greater in patients again indicating increased flow to the spleen. Also of
interest, the ratios of SV flow to PV flow were almost significantly higher in patients
than in normals.
In addition to the lumped comparisons above, the patients were compared in-
dividually with the normal subject averages. For PV velocity D5 had the greatest
difference from both the normal and patient averages. D5 had moderate varices which
means blood was bypassing the PV and liver as well as only mild spleen enlargement
and thus a smaller increase in flow to the SV. While the patients trended to have
increased but not statistically different PV flow, one patient, D2, had a flow rate that
was 80% greater than even the patient average. D2 also had severe spleen enlarge-
ment and only mild varices which means that the flow from the SV was increased
and the flow to the PV was not being diverted by varices. Another patient, D5, had
a 60% decrease in flow from the patient average and had no SV which limited the
SV contribution to the PV flow. For PV flowrate per liver volume D2 and D6 were
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over 1 standard deviation away from the normal average and D4 and D5 were al-
most 1 standard deviation the other way from the normal average. Thus, the patient
and normal averages were not that far apart. The parameter that separates these
two groups is that D2 and D6 have severe spleen enlargement and D4 and D5 have
only marked and mild spleen enlargement. We can then hypothesize that with severe
spleen enlargement the flow increase from the spleen is not a result of an increase
in liver volume since the PV flowrate per liver volume increases. Otherwise if the
liver volume did increase, the flow per liver volume would remain the same. The
SMV flowrate averages for normals and patients were within 8 ml/min. However, D4
had increased SMV flow and only minimal inflammation. Perhaps the low amount of
inflammation allowed the flow to be higher or the patient had recently eaten which
can also increase flow temporarily. D5 and D6 had decreased SMV flowrates and also
moderate varices, which could in addition to diverting blood from the PV also divert
blood from the SMV.
In comparing the CFD models, the patients had greater mixing of the blood and
more rotational flow. The SMV also contributed a majority of its flow to the LPV
versus the RPV as the normal subjects showed. This could be due to changes in the
flow split and increased resistance in the right portion of the liver due to the disease.
However, further work is needed to determine at what stage of disease that change
occurs and if it can be used as a marker or predictive parameter.
9.1 Future Directions
This work is meant to draw preliminary conclusions about the portal venous sys-
tem and apply the MR/CFD methodology. Future work would involve more normal
subjects and more patients including a range of disease stages. The parameters men-
tioned above should be investigated further to see if indeed they are significant or if
any other parameters emerge as significant with the addition of more subjects. Once
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the number of subjects is sufficient, the diagnostic significance or applicability will be
assessed. Further studies may also include before and after meal measurements of the




Cirrhosis is a leading cause of death in the United States and has severe and costly
complications. Because of the clinical significance of cirrhosis, it is important that
noninvasive methods be developed to detect cirrhosis early and to monitor its progres-
sion with advancing liver disease. Previous studies on portal venous hemodynamics
have been performed mainly with ultrasound with mixed results. Magnetic Reso-
nance Imaging offers several advantages over ultrasound including acquisition of both
high quality anatomical and hemodynamic information.
Phase-Contrast MR was used to gather velocity data for the portal venous sys-
tem. Methods were developed to perform registration, segmentation and isolation of
the portal vein geometries and velocity data. Computational Fluid Dynamics was
also employed to further investigate the flow within the portal vein, beginning with
idealized models and then subject specific models.
The idealized models provided a simple initial adaptation of the CFD methodology
and provided some insights that were carried forward to the normal subjects and
patients such as parabolic-like velocity profiles, streamlining in the portal vein and
quasisteady flow assumption.
The data set included nine normal subjects and four patients. Velocity data for
the portal vein, superior mesenteric vein, splenic vein and the right or left portal vein
was acquired in varying numbers for both data sets. Even with the limited number of
subjects a few parameters were significant. Patients with cirrhosis had a significantly
increased portal vein area and a significantly decreased average velocity per liver
volume and velocity variance. Patients with cirrhosis had a significantly increased
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splenic vein area and average flow rate per liver volume. Two other parameters that
were almost significant were a decreased portal vein velocity and an increase in splenic
blood in the portal vein. CFD results showed some interesting differences between
normal subjects and patients which include greater mixing of the blood and more
rotational flow in the patients. Whether the rotational flow is a result of the subject’s
geometry or the disease is yet to be determined. The CFD results also supported
the hypothesis that the superior mesenteric vein predominately feeds the right portal
vein. This was found to be true for the normal subjects but reversed for the patients
perhaps due to the diseased state.
While these results are preliminary due to small sample size, they are promising
and require further investigation and more subjects including varying stages of disease.
The long term clinical significance is to develop non-invasive diagnostic methods to
evaluate and monitor the progression of cirrhosis in patients with chronic liver disease.
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